<SEC-DOCUMENT>0001213900-25-074419.txt : 20250811
<SEC-HEADER>0001213900-25-074419.hdr.sgml : 20250811
<ACCEPTANCE-DATETIME>20250811172823
ACCESSION NUMBER:		0001213900-25-074419
CONFORMED SUBMISSION TYPE:	S-1
PUBLIC DOCUMENT COUNT:		17
FILED AS OF DATE:		20250811
DATE AS OF CHANGE:		20250811

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Brag House Holdings, Inc.
		CENTRAL INDEX KEY:			0001903595
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MISCELLANEOUS AMUSEMENT & RECREATION [7990]
		ORGANIZATION NAME:           	07 Trade & Services
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-289505
		FILM NUMBER:		251203146

	BUSINESS ADDRESS:	
		STREET 1:		45 PARK STREET
		CITY:			MONTCLAIR
		STATE:			NJ
		ZIP:			07042
		BUSINESS PHONE:		413-398-2845

	MAIL ADDRESS:	
		STREET 1:		45 PARK STREET
		CITY:			MONTCLAIR
		STATE:			NJ
		ZIP:			07042
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1
<SEQUENCE>1
<FILENAME>ea0251980-s1_brag.htm
<DESCRIPTION>REGISTRATION STATEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>As filed with the Securities and
Exchange Commission on August 11, 2025</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><B>Registration No. 333- &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM S</B>-<B>1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REGISTRATION STATEMENT UNDER THE SECURITIES
ACT OF 1933</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 100%; border-bottom: black 1.5pt solid; font-size: 10pt; text-align: center"><B>Brag House Holdings, Inc.</B></TD></TR>
  <TR>
    <TD STYLE="font-size: 10pt; text-align: center">(Exact name of registrant as specified in its charter)</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 32%; border-bottom: black 1.5pt solid; text-align: center"><B>Delaware</B></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 32%; border-bottom: black 1.5pt solid; text-align: center"><B>001-42525</B></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 32%; border-bottom: black 1.5pt solid; text-align: center"><B>87-4032622</B></TD></TR>
  <TR>
    <TD STYLE="text-align: center">(State or other jurisdiction of<BR>
    incorporation or organization)</TD>
    <TD>&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Primary Standard Industrial<BR>
    Classification Code Number)</P></TD>
    <TD>&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(I.R.S. Employer<BR>
    Identification No.)</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>45 Park Street</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Montclair,&nbsp;NJ&nbsp;07042</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: black 1.5pt solid"><B>Telephone:
(413)&nbsp;398-2845</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address, including zip code, and telephone number,
including area code, of registrant&rsquo;s principal executive offices)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: black 1.5pt solid"><B>Lavell Juan
Malloy,&nbsp;II<BR>
Chief Executive Officer<BR>
Brag House Holdings Inc.<BR>
45 Park Street,<BR>
Montclair, NJ 07042<BR>
(413) 398-2845</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name, address, including zip code, and telephone
number, including area code, of agent for service)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Please send copies of all communications to:
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>Joseph M. Lucosky, Esq.
<BR>
Steven A. Lipstein, Esq.<BR>
 Lucosky Brookman LLP <BR>
101 Wood Avenue South, 5th Floor<BR>
 Woodbridge, NJ 08830</B> <BR>
<B>(732) 395-4400</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Approximate date of commencement of proposed
sale to the public:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: center"><B>As soon as practicable after the
effective date of this registration statement.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If any of the securities being registered on
this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following
box: <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9746;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is filed to register additional
securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act
registration statement number of the earlier effective registration statement for the same offering: <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is a post-effective amendment filed
pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of
the earlier effective registration statement for the same offering: <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is a post-effective amendment filed
pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of
the earlier effective registration statement for the same offering: <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company.
See the definitions of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer,&rdquo; &ldquo;smaller reporting company,&rdquo;
and &ldquo;emerging growth company&rdquo; in Rule 12b-2 of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 41%">Large accelerated filer</TD>
    <TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></TD>
    <TD STYLE="width: 51%">Accelerated filer</TD>
    <TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></TD></TR>
  <TR>
    <TD>Non-accelerated filer</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9746;</FONT></TD>
    <TD>Smaller reporting company</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9746;</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Emerging growth company</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9746;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Registrant hereby amends this Registration
Statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment that
specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities
Act of 1933 or until the registration statement shall become effective on such date as the Securities and Exchange Commission, acting
pursuant to said Section 8(a), may determine.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 43%"><FONT STYLE="color: Red"><B>PRELIMINARY PROSPECTUS </B></FONT></TD>
    <TD STYLE="width: 28%"><FONT STYLE="color: Red"><B>Subject to Completion </B></FONT></TD>
    <TD STYLE="width: 29%; text-align: right"><FONT STYLE="color: Red"><B>Dated: August 11, 2025</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Red"><B>The information contained
in this preliminary prospectus is not complete and may be changed. These securities may not be sold until the registration statement
filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities
and it is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="image_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Up to 32,904,677 Shares of Common Stock offered
by the Selling Stockholders</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus relates to
the resale, from time to time, of up to 32,904,677 shares (the &ldquo;Shares&rdquo;) of common stock, par value $0.0001 per share (the
&ldquo;Common Stock&rdquo;), of Brag House Holdings, Inc. (the &ldquo;Company&rdquo;), by the selling stockholders identified in this
prospectus under the section &ldquo;Selling Stockholders&rdquo; (the &ldquo;Offering&rdquo;) pursuant to: (i) a Securities Purchase Agreement
dated July 24, 2025 (the &ldquo;Securities Purchase Agreement&rdquo;) with twelve accredited investors (the &ldquo;Investors&rdquo;),
whereby we issued to the Investors: (i) 15,000 shares of Series B Convertible Preferred Stock, par value $0.0001 per share, of Brag House
Holdings, Inc. (&ldquo;Series B Preferred Stock&rdquo;), with each share of Series B Convertible Preferred Stock convertible into approximately
1,061.5711 shares of Common Stock, for an aggregate of 15,923,567 shares of Common Stock (the &ldquo;Conversion Shares&rdquo;) at a conversion
price of $0.942 per share of Series B Preferred Stock; and (ii) a warrant (the &ldquo;PIPE Warrants&rdquo;) to purchase up to an aggregate
of 15,923,567 shares of Common Stock (the &ldquo;Warrant Shares&rdquo;) for a term of five years, at an exercise price of $0.817 per
share, subject to beneficial ownership limitations set by the holder and certain adjustments. The purchase price for one unit (consisting
of one share of Series B Convertible Preferred Stock convertible into approximately 1,061.5711 shares and the same number of PIPE Warrants)
was $1,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the Offering,
on July 24, 2025, Brag House Holdings, Inc. entered into a Placement Agency Agreement with Revere Securities LLC (the &ldquo;Placement
Agent&rdquo;), in which the Placement Agent served as the placement agent in the Offering, and the Company, as part of the compensation
payable to the Placement Agent for services provided by the Placement Agent to the Company in the Offering, issued a warrant (the &ldquo;Placement
Agent Warrants&rdquo; and, collectively with the PIPE Warrants, the &ldquo;Warrants&rdquo;), to purchase an aggregate of 1,057,543 shares
of Common Stock (the &ldquo;Placement Agent Warrant Shares&rdquo; and, collectively with the Conversion Shares and the Warrant Shares,
the &ldquo;Shares&rdquo;) at an exercise price of $0.817 per share, subject to certain adjustments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are not selling any shares
of our Common Stock under this prospectus and will not receive any proceeds from the sale of any Conversion Shares, Warrant Shares or
Placement Agent Warrant Shares by the applicable Selling Stockholders. We would, however, receive proceeds from any Warrants that are
exercised through the payment of the exercise price in cash of such Warrants, in a maximum amount of up to approximately $13,873,567.
The Selling Stockholders will bear all commissions and discounts, if any, attributable to the sale of the Shares. We will bear all costs,
expenses and fees in connection with the registration of the Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No securities may be sold
without delivery of this prospectus and any applicable prospectus supplement describing the method and terms of the offering of such
securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You should read this prospectus,
together with additional information described under the headings &ldquo;Information Incorporated by Reference&rdquo; and &ldquo;Where
You Can Find More Information,&rdquo; carefully before you invest in any of our securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are an &ldquo;emerging
growth company&rdquo; as that term is used in the Jumpstart Our Business Startups Act of 2012 and a &ldquo;smaller reporting company&rdquo;,
and as such, we have elected to take advantage of certain reduced public company reporting requirements for this prospectus and future
filings. Investing in our securities involves a high degree of risk. See &ldquo;Risk Factors&rdquo; beginning on page 5 of this
prospectus for a discussion of information that should be considered in connection with an investment in our securities. See &ldquo;Prospectus
Summary &mdash; Implications of Being an Emerging Growth Company&rdquo; and &ldquo;Prospectus Summary &mdash; Implications of Being a
Smaller Reporting Company.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify"><B>Investing in our securities involves a high
degree of risk. See the section titled &ldquo;Risk Factors&rdquo; beginning on page 5 of this prospectus and in the documents
incorporated by reference into this prospectus for a discussion of risks that should be considered in connection with an investment in
our securities. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Our Common Stock is listed on
The Nasdaq Capital Market LLC (&ldquo;Nasdaq&rdquo;) under the symbol &ldquo;TBH.&rdquo; On August 8, 2025, the last reported sale price
of our Common Stock on Nasdaq was $1.27 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify"><B>Neither the Securities and Exchange Commission
nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus.
Any representation to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>The date of this prospectus is&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; , 2025.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 91%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 9%; text-align: center"><B>Page</B></TD>
    </TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD><A HREF="#a_001">ABOUT THIS PROSPECTUS</A></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">ii</TD>
    </TR>
  <TR STYLE="background-color: White">
    <TD><A HREF="#a_002">CAUTIONARY NOTE CONCERNING FORWARD-LOOKING STATEMENTS</A></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">iii</TD>
    </TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD><A HREF="#a_003">PROSPECTUS SUMMARY</A></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">1</TD>
    </TR>
  <TR STYLE="background-color: White">
    <TD><A HREF="#a_004">THE OFFERING</A></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">4</TD>
    </TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD><A HREF="#a_005">RISK FACTORS</A></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">5</TD>
    </TR>
  <TR STYLE="background-color: White">
    <TD><A HREF="#a_006">USE OF PROCEEDS</A></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">7</TD>
    </TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD><A HREF="#a_007">DILUTION</A></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">7</TD>
    </TR>
  <TR STYLE="background-color: White">
    <TD><A HREF="#a_008">PRIVATE PLACEMENT OF SERIES B PREFERRED STOCK AND WARRANTS</A></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">8</TD>
    </TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD><A HREF="#a_009">SELLING STOCKHOLDERS</A></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">9</TD>
    </TR>
  <TR STYLE="background-color: White">
    <TD><A HREF="#a_010">DESCRIPTION OF CAPITAL STOCK</A></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">13</TD>
    </TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD><A HREF="#a_011">PLAN OF DISTRIBUTION</A></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">16</TD>
    </TR>
  <TR STYLE="background-color: White">
    <TD><A HREF="#a_012">INFORMATION INCORPORATED BY REFERENCE</A></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">18</TD>
    </TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD><A HREF="#a_013">WHERE YOU CAN FIND MORE INFORMATION</A></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">19</TD>
    </TR>
  <TR STYLE="background-color: White">
    <TD><A HREF="#a_014">LEGAL MATTERS</A></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">19</TD>
    </TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD><A HREF="#a_015">EXPERTS</A></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">19</TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_001"></A>ABOUT THIS PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We incorporate by reference important information
into this prospectus. You may obtain the information incorporated by reference without charge by following the instructions under &ldquo;Where
You Can Find More Information.&rdquo; You should carefully read this prospectus as well as additional information described under &ldquo;Information
Incorporated by Reference,&rdquo; before deciding to invest in our securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have not, and the placement agent has not,
authorized anyone to provide any information or to make any representations other than those contained in this prospectus or in any free
writing prospectuses prepared by or on behalf of us or to which we have referred you. We take no responsibility for, and can provide
no assurance as to the reliability of, any other information that others may give you. This prospectus is an offer to sell only the securities
offered hereby, and only under circumstances and in jurisdictions where it is lawful to do so. The information contained in this prospectus
or in any applicable free writing prospectus is current only as of its date, regardless of its time of delivery or any sale of our securities.
Our business, financial condition, results of operations and prospects may have changed since that date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The information incorporated by reference or
provided in this prospectus contains statistical data and estimates, including those relating to market size and competitive position
of the markets in which we participate, that we obtained from our own internal estimates and research, as well as from industry and general
publications and research, surveys and studies conducted by third parties. Industry publications, studies and surveys generally state
that they have been obtained from sources believed to be reliable. While we believe our internal company research is reliable and the
definitions of our market and industry are appropriate, neither this research nor these definitions have been verified by any independent
source.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For investors outside the United States: We have
not, and the placement agent has not, done anything that would permit this offering or possession or distribution of this prospectus
in any jurisdiction where action for that purpose is required, other than in the United States. Persons outside the United States who
come into possession of this prospectus must inform themselves about, and observe any restrictions relating to, the offering of the securities
and the distribution of this prospectus outside the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus and the information incorporated
by reference into this prospectus contain references to our trademarks and to trademarks belonging to other entities. Solely for convenience,
trademarks and trade names referred to in this prospectus and the information incorporated by reference into this prospectus, including
logos, artwork, and other visual displays, may appear without the &reg; or TM symbols, but such references are not intended to indicate,
in any way, that we will not assert, to the fullest extent under applicable law, our rights or the rights of the applicable licensor
to these trademarks and trade names. We do not intend our use or display of other companies&rsquo; trade names or trademarks to imply
a relationship with, or endorsement or sponsorship of us by, any other company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_002"></A>CAUTIONARY NOTE CONCERNING FORWARD-LOOKING
STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Except for historical information, this prospectus
contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;). Forward-looking statements include statements with respect
to our beliefs, plans, objectives, goals, expectations, anticipations, assumptions, estimates, intentions and future performance, and
involve known and unknown risks, uncertainties and other factors, which may be beyond our control, and which may cause our actual results,
performance or achievements to be materially different from future results, performance or achievements expressed or implied by such
forward-looking statements. All statements other than statements of historical fact are statements that could be forward-looking statements.
You can identify these forward-looking statements through our use of words such as &ldquo;may,&rdquo; &ldquo;can,&rdquo; &ldquo;anticipate,&rdquo;
&ldquo;assume,&rdquo; &ldquo;should,&rdquo; &ldquo;indicate,&rdquo; &ldquo;would,&rdquo; &ldquo;believe,&rdquo; &ldquo;contemplate,&rdquo;
&ldquo;expect,&rdquo; &ldquo;seek,&rdquo; &ldquo;estimate,&rdquo; &ldquo;continue,&rdquo; &ldquo;plan,&rdquo; &ldquo;point to,&rdquo;
&ldquo;project,&rdquo; &ldquo;predict,&rdquo; &ldquo;could,&rdquo; &ldquo;intend,&rdquo; &ldquo;target,&rdquo; &ldquo;potential&rdquo;
and other similar words and expressions of the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There are a number of important factors that
could cause the actual results to differ materially from those expressed in any forward-looking statement made by us. These factors include,
but are not limited to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">overall strength and stability of general economic conditions
and of the esports industry in the United&nbsp;States and globally;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">changes in consumer demand for, and acceptance of, our services
and the games that we make available for our tournaments and other experiences, as well as online gaming in general;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">changes in the competitive environment, including adoption
of technologies, services and products that compete with our own;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our ability to generate consistent revenue;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our ability to effectively execute our business plan;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">changes in the price of streaming services, licensing fees,
network infrastructure, hosting and maintenance;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">changes in laws or regulations governing our business and
operations;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our ability to maintain proper and effective internal controls;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our ability to maintain adequate liquidity and financing sources
and an appropriate level of debt on terms favorable to us;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our ability to effectively market our services;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">costs and risks associated with, and the outcome of any known
or unknown litigation;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our ability to obtain and protect our existing intellectual
property protections, including patents, trademarks and copyrights;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our ability to obtain and enter into new licensing agreements
with game publishers and owners;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">changes in accounting principles, or their application or
interpretation, and our ability to make estimates and the assumptions underlying the estimates, which could have an effect on earnings;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">interest rates and the credit markets; and</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">other risks and uncertainties described under the heading
&ldquo;Risk Factors&rdquo; and elsewhere in our annual report on Form 10-K for the year ended December 31, 2024 (the &ldquo;Annual Report&rdquo;).</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing does not represent an exhaustive
list of matters that may be covered by the forward-looking statements contained herein or risk factors that we are faced with that may
cause our actual results to differ from those anticipated in such forward-looking statements. The events and circumstances reflected
in our forward-looking statements may not be achieved or occur and actual results could differ materially from those projected in the
forward-looking statements. You should refer to the &ldquo;Risk Factors&rdquo; section of this prospectus for a discussion of important
factors that may cause our actual results to differ materially from those expressed or implied by our forward-looking statements. You
should review the factors and risks and other information we describe in the reports we will file from time to time with the Securities
and Exchange Commission (the &ldquo;SEC&rdquo;) after the date of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All forward-looking statements are expressly
qualified in their entirety by this cautionary note. You are cautioned to not place undue reliance on any forward-looking statements,
which speak only as of the date of this prospectus or the date of the document incorporated by reference into this prospectus. You should
read this prospectus and the documents that we reference in this prospectus and have filed as exhibits to the registration statement,
of which this prospectus is a part, completely and with the understanding that our actual future results may be materially different
from what we expect. We have no obligation, and expressly disclaims any obligation, to update, revise or correct any of the forward-looking
statements, whether as a result of new information, future events or otherwise. We have expressed our expectations, beliefs and projections
in good faith and believe they have a reasonable basis. However, we cannot assure you that our expectations, beliefs or projections will
result or be achieved or accomplished.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iv<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<DIV STYLE="padding: 5pt; border: Black 1.5pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_003"></A>PROSPECTUS SUMMARY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>This summary highlights information about
our company, this offering and information contained in greater detail in other parts of this prospectus or incorporated by reference
into this prospectus from our filings with the SEC listed in the section titled &ldquo;Information Incorporated by Reference.&rdquo;
Because it is only a summary, it does not contain all of the information that you should consider before purchasing our securities in
this offering and it is qualified in its entirety by, and should be read in conjunction with, the more detailed information appearing
elsewhere or incorporated by reference into this prospectus. You should read the entire prospectus, the registration statement of which
this prospectus is a part, and the information incorporated by reference into this prospectus in their entirety, including the &ldquo;Risk
Factors&rdquo; and our financial statements and the related notes incorporated by reference into this prospectus, before purchasing our
securities in this offering. Except as otherwise indicated herein or as the context otherwise requires, references in this prospectus
to &ldquo;Brag House&rdquo; &ldquo;the Company,&rdquo; &ldquo;we,&rdquo; &ldquo;us&rdquo; and &ldquo;our&rdquo; refer to Brag House Holdings,
Inc.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Corporate Overview</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Brag House is a mission-driven organization that
utilizes a diversified business strategy to operate a vertically integrated platform designed for casual college gamers to drive community-driven
gaming experiences anchored in the college sports culture, while creating authentic pathways for brands to connect with our Gen Z audience.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Brag House is a Delaware corporation formed in
December&nbsp;2021. Our founders developed the idea for the Brag House platform in 2018, when our Chief Executive Officer Lavell Juan
Malloy,&nbsp;II and co-founder, Chief Operating Officer Daniel Leibovich recognized a need in the gaming industry for an esports platform
focused specifically on the casual college gamer, and formed our indirect wholly-owned subsidiary, BHI.&nbsp;At that time, our co-founders
believed that a significant amount of industry resources were focused predominantly on competitive and professional gamers, much to the
detriment of casual gamers, generally, and casual college gamers, specifically. In the&nbsp;years ensuing, we have maintained our focus
on the casual college gaming segment and believe we are developing a first-of-its-kind digital platform for casual college gamers to
compete, support their team, banter in a safe environment and win prizes. Our vertically integrated approach combines gamer recruitment,
facilitation of community engagement and content creation, live-stream production and tournament host activities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe we are creating a new sports entertainment
medium for Gen Z to engage&nbsp;through gaming by merging gameplay with school spirit in Brag House and student-led activations and tournaments
tied to college rivalries with Brag House features and capabilities such as our Bragging Functionality, Loyalty Tokens reward system,
and brand-sponsored content and prizes.&nbsp;The growth of our platform since our inception is encouraging, and we believe we are strongly
positioned to capitalize on a large portion of the available gaming market. We experienced strong community growth since we launched
through June 30 , 2025, reaching nearly 1,400,000 video views of our Brag House Content on video platforms including X (formerly known
as Twitter), TikTok, Meta, Twitch and YouTube, which represent a 107 % increase in views year-over-year from 2020 to 2025 . We have also
generated nearly 8.5 &nbsp;million impressions and video views since inception, which represents approximately a 45 % increase year-over-year
from 2020 to 2025 . Additionally, since 2022, Brag House spectators who viewed live streams remained on the platform for 19 minutes per
live stream across over 290,000 live views, which represents nearly a 1.75X increase compared to the industry benchmark of 11 minutes.
This growth suggests that Brag House has the potential to become an important component of the infrastructure for everyday gamers which,
in turn, will lead to accretive synergies in the greater esports ecosystem. In addition, our digital properties, including our mobile
application and website, provide a level of scale which brings players and spectators together across the United&nbsp;States, both digitally
and physically. As the world works to return to a state of normalcy from the impact of COVID-19, we believe live experiences will provide
another source of connection to augment our digital experience. We believe this dynamic, coupled with our personalized experiential framework,
offers a uniquely authentic and differentiated channel for advertisers to utilize, making the otherwise elusive demographic of Gen Z
and Millennial gamers and streamers accessible at scale.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are focused on creating an organic and inclusive
community which facilitates personalized experiences. We believe our experiential framework offers a more authentic and differentiated
channel for advertisers to utilize, making the otherwise elusive demographic of gamers and streamers accessible at scale to ourselves
and our partners. We do this by offering brand sponsors and advertisers an exclusive marketing channel to reach elusive Gen Z and Millennial
gamers and creators, while offering players ways to access exclusive tournaments and programming.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

</DIV>

<!-- Field: Page; Sequence: 8; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 5pt; border: Black 1.5pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In May 2025, we launched the first activation
under our strategic partnership with Learfield. This activation were for students at the University of Florida. We believe this partnership
gave us access to media rights and assets across nearly 200 universities, enabling physical and digital activations. These activations
will integrate sponsorship branding and messaging across our platform and universities&rsquo; assets with pricing and value delivery
defined through a structured commercial model.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In July 2025, we executed the second activation under our strategic partnership with Learfield, expanding on the success of our initial
May 2025 event. This activation was conducted virtually and designed to engage students and alumni through a digital tournament centered
around EA College Football 26, following the game&rsquo;s national release. The event incorporated university-branded content and featured
participation from student-athletes, further aligning with our Name, Image, and Likeness (&ldquo;NIL&rdquo;) engagement strategy. We
believe this activation demonstrated our ability to scale digital experiences across collegiate communities and reinforced our commercial
model for integrating sponsorship, branded content, and fan engagement at the intersection of gaming and college sports.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Additionally, we are advancing a data monetization
strategy. The goal is to develop a proprietary machine learning-based SaaS platform designed to offer anonymized predictive data insights
into Gen Z behavior for brand clients. Development began post-IPO, in March 2025, with a beta version expected in Q3 2026.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Reverse Stock Split</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On October&nbsp;11, 2024, we filed an amendment
to our certificate of incorporation, as amended, with the Secretary of State of the State of Delaware to effect a 1 for 2.43615 consolidation
of our issued and outstanding Common Stock and Preferred Stock (the &ldquo;Reverse Stock Split&rdquo;). Any future redemption of stock
options or warrants for options or warrants that were granted prior to October&nbsp;11, 2024 will also reflect the Reverse Stock Split.
The Company is in the process of paying for the Fractional Shares, which total $85.81, to its shareholders that were affected by the
Reverse Stock Split. Unless otherwise noted, the share and per share information in this prospectus reflects the Reverse Stock Split.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Implications of Being an Emerging Growth Company
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are an emerging growth company as defined
in the Jumpstart Our Business Startups Act of 2012. We will remain an emerging growth company until the earliest to occur of: the last
day of the fiscal year in which we have more than $1.235 billion in annual revenues; the date we qualify as a &ldquo;large accelerated
filer&rdquo;; the issuance, in any three-year period, by us of more than $1.0 billion in non-convertible debt securities; and the last
day of the fiscal year ending after the fifth anniversary of our first sale of common equity securities pursuant to a U.S. registration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As an emerging growth company, we may take advantage
of certain exemptions from various reporting requirements that are applicable to other publicly traded entities that are not emerging
growth companies. These exemptions include: (i) the option to present only two years of audited financial statements and related discussion
in the section titled &ldquo;Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations&rdquo; in our
filings with the SEC; (ii) not being required to comply with the auditor attestation requirements of Section 404(b) of the Sarbanes-Oxley
Act of 2002; (iii) not being required to comply with any requirement that may be adopted by the Public Company Accounting Oversight Board,
or PCAOB, regarding mandatory audit firm rotation or a supplement to the auditor&rsquo;s report providing additional information about
the audit and the financial statements (i.e., an auditor discussion and analysis); (iv) not being required to submit certain executive
compensation matters to shareholder advisory votes, such as &ldquo;say-on-pay,&rdquo; &ldquo;say-on-frequency,&rdquo; and &ldquo;say-on-golden
parachutes&rdquo;; and (v) not being required to disclose certain executive compensation related items such as the correlation between
executive compensation and performance and comparisons of the chief executive officer&rsquo;s compensation to median employee compensation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 5pt; border: Black 1.5pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Implications of Being a Smaller Reporting
Company</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are a &ldquo;smaller reporting company&rdquo;
as defined in Item 10(f)(1) of Regulation S-K. Smaller reporting companies may take advantage of certain reduced disclosure obligations,
including, among other things, providing only two years of audited financial statements. We will remain a smaller reporting company until
the last day of any fiscal year for so long as either (1) the market value of our shares of common stock held by non-affiliates does
not equal or exceed $250.0 million as of the prior June 30th, or (2) our annual revenues did not equal or exceed $100.0 million during
such completed fiscal year and the market value of our shares of common stock held by non-affiliates did not equal or exceed $700.0 million
as of the prior June 30th. To the extent we take advantage of any reduced disclosure obligations, it may make comparison of our financial
statements with other public companies difficult or impossible.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Corporate Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We were formed as a Delaware corporation in December&nbsp;2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Brag House, Inc. (&ldquo;BHI&rdquo;), the Company&rsquo;s
wholly owned indirect subsidiary and the entity through which our operations are primarily conducted, was formed as a Delaware corporation
in February&nbsp;2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On June&nbsp;11, 2021, Brag House, Ltd. (&ldquo;BHL&rdquo;)
was registered in the United Kingdom. Their principal offices are located at 7&nbsp;&ndash;&nbsp;9 Swallow Street, London W1B 4DE, United
Kingdom.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August&nbsp;16, 2021, BHL acquired all of
the 10,000,000 issued and outstanding BHI shares held by BHI shareholders on a one for 14.07 basis (rounded to the nearest whole number)
in exchange for 140,700,000 ordinary shares of &pound;0.0001 in BHL, making BHI a wholly owned subsidiary of BHL (&ldquo;UK Reorganization&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Following the UK Reorganization, the board of
directors of BHL determined that it was in the best interests of BHL and its shareholders that an initial public offering in the United&nbsp;States
and concurrent listing on The Nasdaq Stock Market (&ldquo;Nasdaq&rdquo;) be pursued. To effect that proposed initial public offering
and listing on Nasdaq, in December&nbsp;2021, the Company was formed. On February&nbsp;8, 2022, the Company approved a reorganization,
in which the shareholders of BHL would exchange their ordinary shares and preference shares of BHL for a proportionate number of common
and preferred shares in the Company on a 21 to 1 basis (&ldquo;U.S.&nbsp;Reorganization&rdquo;). Immediately following the U.S.&nbsp;Reorganization,
BHL became the wholly-owned&nbsp;subsidiary of the Company, and BHI became the indirect wholly-owned&nbsp;subsidiary of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We anticipate that BHL will be wound down and
dissolved as soon as reasonably practicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our principal executive offices are located at
45 Park Street, Montclair, NJ 07042 and our telephone number is 413-398-2845. Our website address is&nbsp;<I>www.braghouse.com</I>. The
investor relations portion of our website is available at&nbsp;<I>corp.braghouse.com</I>. The references to our website addresses do
not constitute incorporation by reference of the information contained at or available through our websites, and you should not consider
it to be a part of this prospectus. We have included our website addresses in this prospectus solely as inactive textual references.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</DIV>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 5pt; border: Black 1.5pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B><A NAME="a_004"></A>THE OFFERING</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="text-align: left; vertical-align: top; width: 30%; padding: 1.5pt"><B>Issuer</B></TD>
    <TD STYLE="width: 1%; padding: 1.5pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt; vertical-align: bottom; width: 69%; text-align: left">Brag House Holdings, Inc.</TD></TR>
  <TR>
    <TD STYLE="text-align: left; vertical-align: top; padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt; vertical-align: bottom; text-align: left">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: left; vertical-align: top; padding: 1.5pt"><B>Shares of Common Stock offered by us</B></TD>
    <TD STYLE="padding: 1.5pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt; vertical-align: bottom; text-align: left">None.</TD></TR>
  <TR>
    <TD STYLE="text-align: left; vertical-align: top; padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt; vertical-align: bottom; text-align: left">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: left; vertical-align: top; padding: 1.5pt"><B>Shares of Common Stock offered by the Selling Stockholders </B>&nbsp;</TD>
    <TD STYLE="padding: 1.5pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt; vertical-align: bottom; text-align: left">32,904,677 <SUP>(1)</SUP> shares</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding: 1.5pt; text-align: left">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: left; vertical-align: top; padding: 1.5pt"><B>Shares of Common Stock outstanding before the Offering</B></TD>
    <TD STYLE="padding: 1.5pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt; vertical-align: bottom; text-align: left">10,822,588<SUP></SUP> shares</TD></TR>
  <TR>
    <TD STYLE="text-align: left; vertical-align: top; padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt; vertical-align: bottom; text-align: left">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: left; vertical-align: top; padding: 1.5pt"><B>Shares of Common Stock outstanding after completion of this <B>Offering assuming</B>
    the sale of all shares offered hereby</B></TD>
    <TD STYLE="padding: 1.5pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt; vertical-align: bottom; text-align: left">43,727,265<SUP></SUP> shares</TD></TR>

<TR>
    <TD STYLE="text-align: left; vertical-align: top; padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt; vertical-align: bottom; text-align: left">&nbsp;</TD></TR>
<TR>
    <TD STYLE="padding: 1.5pt; vertical-align: top; text-align: left"><B>Use of Proceeds </B></TD>
    <TD STYLE="padding: 1.5pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt; vertical-align: bottom; text-align: justify">We will not receive any proceeds from the resale
    of the Common Stock by the Selling Stockholders. We would, however, receive proceeds from any Warrants that are exercised through
    the payment of the exercise price in cash of such Warrants, in a maximum amount of up to approximately $13,873,567.</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding: 1.5pt; text-align: left">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="padding: 1.5pt; vertical-align: top; text-align: left"><B>Risk Factors </B></TD>
    <TD STYLE="padding: 1.5pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt; vertical-align: bottom; text-align: justify">An investment in our securities involves a high degree of risk.
    See &ldquo;Risk Factors&rdquo; beginning on page 5 of this prospectus and the other information included and incorporated
    by reference in this prospectus for a discussion of the risk factors you should carefully consider before deciding to invest in our
    securities.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="text-align: left; width: 0.25in; padding: 1.5pt; vertical-align: top">(1)</TD>
    <TD STYLE="text-align: justify; padding: 1.5pt">Assumes (i) the conversion of the Series B Preferred Stock at a conversion price of $0.942
    per share, (ii) the exercise of the PIPE Warrants exercisable into 15,923,567 shares of the Company&rsquo;s Common Stock at an exercise
    price of $0.817 per share, and (iii) the exercise of the Placement Agent Warrants exercisable into 1,057,543 shares of Common Stock
    at an exercise price of $0.817 per share.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</DIV>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><A NAME="a_005"></A>RISK FACTORS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Before purchasing any of the securities you
should carefully consider the risk factors set forth below and incorporated by reference in this prospectus from our Annual Report, and
any subsequent updates described in our Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, as well as the risks, uncertainties
and additional information set forth in our SEC reports on Forms 10-K, 10-Q, and 8-K and in the other documents incorporated by reference
in this prospectus. For a description of these reports and documents, and information about where you can find them, see &ldquo;Additional
Information&rdquo; and &ldquo;Incorporation of Certain Information By Reference.&rdquo; Additional risks not presently known or that
we presently consider to be immaterial could subsequently materially and adversely affect our financial condition, results of operations,
business, and prospects.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We have not produced significant revenues.
This makes it difficult to evaluate our future prospects and increases the risk that we will not be successful.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our operations since inception have produced
limited revenues and may not produce significant revenues in the near term, or at all, which may harm our ability to obtain additional
financing and may require us to reduce or discontinue our operations. You must consider our business and prospects in light of the risks
and difficulties we will encounter as a company operating in a rapidly evolving industry. We may not be able to successfully address
these risks and difficulties, which could significantly harm our business, operating results, and financial condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Our history of recurring losses and anticipated
expenditures raises substantial doubt about our ability to continue as a going concern. Our ability to continue as a going concern requires
that we obtain sufficient funding to finance our operations.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have incurred operating losses to date and it is possible we may
never generate a profit. Our financial statements included in our Annual Report have been prepared on a going concern basis, which contemplates
the realization of assets and satisfaction of liabilities in the ordinary course of business. If we are unable to raise sufficient capital
as and when needed, our business, financial condition and results of operations will be materially and adversely affected, and we will
need to significantly modify our operational plans to continue as a going concern. If we are unable to continue as a going concern, we
may have to liquidate our assets, and the values we receive for our assets in liquidation or dissolution could be significantly lower
than the values reflected in our consolidated financial statements. Our lack of cash resources and our potential inability to continue
as a going concern may materially adversely affect our share price and our ability to raise new capital, enter into critical contractual
relations with third parties and otherwise execute our development strategy. We incurred a net loss of $1,067,673 and $1,034,161 for the
three months ended March 31, 2025 and 2024, respectively, and $3,288,519 and $4,672,348 for the years ended December&nbsp;31, 2024 and
2023, respectively. Our accumulated deficit was $15,715,375 and $14,647,702 as of March 31, 2025 and December
31, 2024, respectively.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The net loss of $1,067,673 for the three months
ended March 31, 2025 included interest expense and amortization of debt discount of $337,928 and $100,781, respectively. These specific
expenses have not been incurred starting in Q2 2025 due to the conversion, at the closing of the IPO,&nbsp;of all of the Original Issue
Discount Convertible Promissory Notes outstanding prior to the IPO. While the Company may incur debt within the next 12&nbsp;months,
the Company does not expect interest expense and amortization of debt discount to be as high in 2025 as it was in 2023 and 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We may encounter unforeseen expenses, difficulties,
complications, delays, and other unknown factors that may adversely affect our financial condition. Our prior losses and expected future
losses have had, and will continue to have, an adverse effect on our financial condition.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If our esports platform does not achieve sufficient
market acceptance and our revenues do not increase significantly, we may never become profitable. Even if we achieve profitability in
the future, we may not be able to sustain profitability in subsequent periods. Our failure to become and remain profitable would decrease
the value of our company and could impair our ability to raise capital, expand our business, diversify our product offerings or continue
our operations. A decline in the value of our company could cause you to lose all or part of your investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Our failure to maintain compliance with
Nasdaq&rsquo;s continued listing requirements could result in the desilting of our securities.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our common stock is currently listed on the Nasdaq
Capital Market. Continued listing of a security on Nasdaq Capital Market is conditioned upon compliance with various continued listing
standards. In the past, we have received notices from Nasdaq&rsquo;s Listing Qualifications Department indicating that we had not complied
with certain of the Nasdaq Capital Market&rsquo;s continued listing standards. A delisting could substantially decrease trading in our
common stock, adversely affect the market liquidity of our common stock as a result of the loss of market efficiencies associated with
Nasdaq and the loss of federal preemption of state securities laws, adversely affect our ability to obtain financing on acceptable terms,
if at all, and may result in the potential loss of confidence by investors, suppliers, and employees and lead to fewer business development
opportunities. Additionally, the market price of our common stock may decline further, and stockholders may lose some or all of their
investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event of a delisting, we anticipate that
we would take actions to restore our compliance with the Nasdaq Capital Market or another national exchange&rsquo;s listing requirements,
but we can provide no assurance that any such action taken by us would allow our common stock to regain listing on the Nasdaq Capital
Market, stabilize our market price, improve the liquidity of our common stock, prevent our common stock from dropping below the Nasdaq
Capital Market&rsquo;s minimum bid price requirement, or prevent future non-compliance with the Nasdaq Capital Market or another national
securities exchange&rsquo;s listing requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>You will experience immediate and substantial
dilution.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Since the price per share of the Common Stock
being offered is substantially higher than the net tangible book value per share of the Common Stock, you will suffer substantial dilution
in the net tangible book value of the common stock you purchase in this offering. The exercise of our outstanding stock options and warrants
could result in further dilution of your investment. See the section titled &ldquo;Dilution&rdquo; below for a more detailed illustration
of the dilution you would incur if you participate in this offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Our stockholders may be subject to dilution
resulting from future offerings of common stock by us.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may raise additional funds in the future by
issuing common stock or equity-linked securities. Holders of our securities have no preemptive rights in connection with such further
issuances. Our board of directors has the discretion to determine if an issuance of our capital stock is warranted, the price at which
such issuance is to be effected and the other terms of any future issuance of capital stock. In addition, additional common stock will
be issued by us in connection with the exercise of options or grant of other equity awards granted by us. Such additional equity issuances
could, depending on the price at which such securities are issued, substantially dilute the interests of the holders of our existing
securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>There are risks, including stock market
volatility, inherent in owning the Common Stock.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The market price and volume of the Common Stock
have been, and may continue to be, subject to significant fluctuations. These fluctuations may arise from general stock market conditions,
the impact of risk factors described herein on our results of operations and financial position, or a change in opinion in the market
regarding our business prospects, financial performance and other factors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The Selling Stockholders may sell their
shares of Common Stock in the open market, which may cause our stock price to decline.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Stockholders may sell their shares
of Common Stock being registered in this offering in the public market. That means that up to 32,904,677 shares of Common Stock, the
number of shares being registered in this offering for sale by the Selling Stockholders, may be sold in the public market. Such sales
will likely cause our stock price to decline.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Sale of our common stock by the Selling
Stockholders could encourage short sales by third parties, which could contribute to the further decline of our stock price.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The significant downward pressure on the price
of our Common Stock caused by the sale of material amounts of Common Stock could encourage short sales by third parties. Such an
event could place further downward pressure on the price of our Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_006"></A>USE OF PROCEEDS</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are not selling any securities in this prospectus.
All proceeds from the resale of the shares of our Common Stock offered by this prospectus will belong to the Selling Stockholders. We
will not receive any proceeds from the resale of the shares of our Common Stock by the Selling Stockholders. We may receive proceeds
from future cash exercises of the Warrants, which, if exercised in cash at the current exercise price with respect to all 16,981,110
shares of Common Stock, would result in gross proceeds of approximately $13,873,567 to us.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_007"></A>DILUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The issuance of our Common Stock to the selling
stockholders will have a dilutive impact on our stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our net tangible book value represents total
tangible assets less total liabilities divided by the number of shares of Common Stock outstanding on March 31, 2025. As of March 31,
2025, we had a historical net tangible book value  of $1,446,355, or $0.13 per share of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">After giving effect to the issuance of 32,904,677 shares of our Common
Stock to the Selling Stockholders, and after deducting estimated offering expenses payable by us, our as-adjusted net tangible book value
as of March 31, 2025 would have been approximately $28,998,716, or $0.66 per share. This represents an immediate increase in net tangible
book value of $0.53 per share to existing stockholders and an immediate dilution of $0.28 per share to new investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table illustrates this per share
dilution:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; width: 76%">Net tangible book value  per share as of March 31, 2025</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">0.13</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Increase in net tangible book value  per share attributable to the effect of this offering</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.53</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">As adjusted net tangible book value  per share after giving effect to this offering</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.66</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Dilution in net tangible book value  per share to new investors</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.28</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The calculations above are based on 10,723,908
shares of our Common Stock outstanding as of March 31, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_008"></A>PRIVATE PLACEMENT OF SERIES B PREFERRED STOCK
AND WARRANTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July 24, 2025, we entered
into a Securities Purchase Agreement with the Investors for the private placement of 15,000 shares of Series B Convertible Preferred
Stock, convertible into an aggregate of 15,923,567 shares of our Common Stock at a conversion price of $0.942 per share, and PIPE Warrants,
each having the right to purchase one share of Common Stock, to acquire up to an aggregate of 15,923,567 shares of Common Stock. The
purchase price for one share of Series B Convertible Preferred Stock convertible into approximately 1,061.5711 shares and a warrant to
purchase the same number of shares was $1,000. The Private Placement closed on July 24, 2025 with aggregate gross proceeds totaling approximately
$15 million to us, before deducting placement agent fees and other expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The PIPE Warrants have an
exercise price of $0.817 per share. Each PIPE Warrant is exercisable immediately and will expire five years from the date of issuance.
The exercise price and number of shares of Common Stock issuable upon exercise of the PIPE Warrants is subject to appropriate adjustment
in the event of stock dividends, stock splits, reorganizations or similar events affecting the Common Stock and the exercise price. Subject
to limited exceptions, the Investors may not exercise any portion of the PIPE Warrants to the extent that the Investors would beneficially
own more than 4.99% (or, at the election of the holder prior to the date of issuance, 9.99%) of the outstanding Common Stock after exercise.
In the event of certain fundamental transactions, the holders of the PIPE Warrants will have the right to receive the Black Scholes Value
(as defined in the PIPE Warrants) of its PIPE Warrants calculated pursuant to a formula set forth in the PIPE Warrants, payable in cash.
There is no trading market available for the PIPE Warrants on any securities exchange or nationally recognized trading system. We do
not intend to list the PIPE Warrants on any securities exchange or nationally recognized trading system.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the Amendment to Placement Agent Agreement, dated as of
July 31, 2025, for a period of eighteen (18) months after the closing date, the Placement Agent shall have the right of first refusal
to participate with respect to any offering involving (i) future equity or equity-linked securities of the Company or (ii) debt of the
Company, which is convertible into equity or in which there is an equity component.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Revere Securities, LLC acted
as placement agent in connection with the Offering pursuant to that certain Placement Agency Agreement dated as of July 24, 2025, between
us and the Placement Agent, pursuant to which we paid the Placement Agent (i) a cash fee equal to 8.00% of the aggregate gross proceeds
from the sale of the shares of the Series B Preferred Stock in the Offering, provided, however, that the cash fee for the proceeds that
were not sourced by the Placement Agent was 6.00% and (ii) reimbursement for certain of out-of-pocket expenses, including (a) legal fees
of $150,000 and (b) up to $50,000 in documented out-of-pocket expenses incurred in connection with the Offering, excluding legal fees.
In addition, we issued to the Placement Agent or its designees the Placement Agent Warrants to purchase up to an aggregate of 1,057,543
shares of Common Stock (6.0% of 10,817,123 and 8.0% of 5,106,444 shares of Common Stock sold in the Offering). The Placement Agent Warrants
have identical terms as the PIPE Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_009"></A>SELLING STOCKHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are registering the shares
of our Common Stock in order to permit the Selling Stockholders to offer the Shares for resale from time to time. Except as otherwise
described in the footnotes to the table below and for the ownership of the registered shares issued to the Selling Stockholders, neither
the Selling Stockholders nor any of the persons that control them has had any material relationships with us or our affiliates within
the past three (3) years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The table below lists the
Selling Stockholders and other information regarding the beneficial ownership (as determined under Section 13(d) of the Securities Exchange
Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;) (and the rules and regulations thereunder) of the Shares of our Common Stock
by the Selling Stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The second column lists the
number of shares of our Common Stock beneficially owned by each Selling Stockholder before this Offering (including shares which the
Selling Stockholders have the right to acquire immediately, including upon exercise of any Warrants).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The third column lists the
Shares of our Common Stock being offered by this prospectus by each Selling Stockholder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The fourth and fifth columns
list the number of shares of Common Stock beneficially owned by each Selling Stockholder and their percentage ownership after the Offering
(including shares which the Selling Stockholder has the right to acquire immediately, including upon exercise of any Warrants), assuming
the sale of all of the Shares offered by each Selling Stockholder pursuant to this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the terms of the Warrants,
a Selling Stockholder may not exercise the Warrants to the extent such conversion or exercise would cause such Selling Stockholder, together
with any other person with which the Selling Stockholder is considered to be part of a group under Section 13 of the Exchange Act or
with which the Selling Stockholder otherwise files reports under Section 13 and/or 16 of the Exchange Act, to beneficially own a number
of shares of Common Stock which exceeds 9.99% of the equity interests of a class that is registered under the Exchange Act that is outstanding
at such time. The number of shares in the third column does not reflect this limitation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The amounts and information
set forth below are based upon information provided to us by the Selling Stockholders as of July 31, 2025, except as otherwise noted
below. The Selling Stockholders may sell all or some of the shares of Common Stock they are offering, and may sell, unless indicated
otherwise in the footnotes below, shares of our Common Stock otherwise than pursuant to this prospectus. The tables below assume the
Selling Stockholders sell all of the shares offered by them in offerings pursuant to this prospectus, and do not acquire any additional
shares. We are unable to determine the exact number of shares that will actually be sold or when or if these sales will occur.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">Selling Stockholder</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of Shares Owned Before Offering</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares Offered Hereby</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number of Shares Owned After Offering<SUP>(1)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Percentage of Shares Beneficially Owned After Offering</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revere Securities LLC<SUP>(2)</SUP></FONT></TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">0</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">1,057,543</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">0</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">0</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Erica Groussman<SUP>(3)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,061,572</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">420 Investments Group, LP<SUP>(4)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,494,692</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">420 Investments LLC<SUP>(5)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,139,554</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adam Cavise<SUP>(6)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">711,826</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Akaa Family LLLP<SUP>(7)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,123,142</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Baja Portfolios LLC<SUP>(8)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">106,156</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eleven Ventures LLC<SUP>(9)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,246,284</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Francis Ong<SUP>(10)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">212,314</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jim McCabe<SUP>(11)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,061,572</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tiger Capital Puerto Rico LLC<SUP>(12)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">212,314</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Turnpoint Capital LLC<SUP>(13)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">318,472</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">William Moreno<SUP>(14)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">159,236</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">%</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">(1)</TD>
    <TD STYLE="text-align: justify">This column assumes full conversion or exercise of the Series B Preferred Stock and Warrants owned by the Selling Stockholders into or for shares of Common Stock offered hereby and the subsequent sale of all such shares of Common Stock.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>(2)</TD>
    <TD STYLE="text-align: justify">Based upon information provided by Revere Securities LLC (&ldquo;Revere&rdquo;),
Revere is the beneficial owner of Placement Agent Warrants to purchase 1,057,543 shares of Common Stock. Revere has a limitation on the
amount of its beneficial ownership pursuant to the placement agent common stock purchase warrant agreement with the Company pursuant to
which Revere will not exercise its Placement Agent Warrants if, following such exercise, Revere would own more than 4.99% of the Company&rsquo;s
issued and outstanding shares of Common Stock. William Moreno, the Executive Chairman of Revere, exercises voting and dispositive power
over the shares being offered under this prospectus. The address of Revere is 560 Lexington Avenue &ndash; 16th Floor, New York, NY 10022.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">(3)</TD>
    <TD STYLE="text-align: justify">Based upon information provided by Erica Groussman, Erica Groussman
is the beneficial owner of Series B Preferred Stock at an aggregate principal amount of $500,000 convertible into 530,786 shares of Common
Stock, and PIPE warrants to purchase up to 530,786 shares of Common Stock. Erica Groussman has a limitation on the amount of her beneficial
ownership in the Securities Purchase Agreement with the Company pursuant to which Ms. Groussman will not exercise her PIPE Warrants if,
following such exercise, Ms. Groussman would own more than 4.99% of the Company&rsquo;s issued and outstanding shares of Common Stock.
The securities are directly held by Erica Groussman. The address of Erica Groussman is 6203 Laguna Path N, Miami Beach, FL 33141.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">(4)</TD>
    <TD STYLE="text-align: justify">Based upon information provided by 420 Investments Group, LP, 420 Investments Group, LP is the beneficial owner of Series B Preferred Stock at an aggregate principal amount of $3,530,000 convertible into 3,747,346 shares of Common Stock, and PIPE warrants to purchase up to 3,747,346 shares of Common Stock. 420 Investments Group, LP has a limitation on the amount of its beneficial ownership in the Securities Purchase Agreement with the Company pursuant to which 420 Investments Group, LP will not exercise its PIPE Warrants if, following such exercise, 420 Investments Group, LP would own more than 4.99% of the Company&rsquo;s issued and outstanding shares of Common Stock. Brad Morris, the Co-Manager of 420 Investments Group, LP, exercises voting and dispositive power over the shares being offered under this prospectus. The address of 420 Investments Group, LP is 1999 Bryan St., Suite 900, Dallas, TX 75201.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">(5)</TD>
    <TD STYLE="text-align: justify">Based upon information provided by 420 Investments LLC, 420 Investments LLC is the beneficial owner of Series B Preferred Stock at an aggregate principal amount of $6,659,730 convertible into 7,069,777 shares of Common Stock, and PIPE warrants to purchase up to 7,069,777 shares of Common Stock. 420 Investments LLC has a limitation on the amount of its beneficial ownership in the Securities Purchase Agreement with the Company pursuant to which 420 Investments LLC will not exercise its PIPE Warrants if, following such exercise, 420 Investments LLC would own more than 4.99% of the Company&rsquo;s issued and outstanding shares of Common Stock. Brad Morris, the Co-Manager of 420 Investments LLC, exercises voting and dispositive power over the shares being offered under this prospectus. The address of 420 Investments LLC is 1999 Bryan St., Suite 900, Dallas, TX 75201.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.35in">(6)</TD>
    <TD STYLE="text-align: justify">Based upon information provided by Adam Cavise, Adam Cavise is the beneficial owner of Series B Preferred Stock at an aggregate principal amount of $335,270 convertible into 355,913 shares of Common Stock, and PIPE warrants to purchase up to 355,913 shares of Common Stock. Adam Cavise has a limitation on the amount of his beneficial ownership in the Securities Purchase Agreement with the Company pursuant to which Mr. Cavise will not exercise his PIPE Warrants if, following such exercise, Mr. Cavise would own more than 4.99% of the Company&rsquo;s issued and outstanding shares of Common Stock. The securities are directly held by Adam Cavise. The address of Adam Cavise is 18 Edgewood Road, Rumson, NJ 07760.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">(7)</TD>
    <TD STYLE="text-align: justify">Based upon information provided by Akaa Family LLLP, Akaa Family LLLP is the beneficial owner of Series B Preferred Stock at an aggregate principal amount of $1,000,000 convertible into 1,061,571 shares of Common Stock, and PIPE warrants to purchase up to 1,061,571 shares of Common Stock. Akaa Family LLLP has a limitation on the amount of its beneficial ownership in the Securities Purchase Agreement with the Company pursuant to which Akaa Family LLLP will not exercise its PIPE Warrants if, following such exercise, Akaa Family LLLP would own more than 4.99% of the Company&rsquo;s issued and outstanding shares of Common Stock. Anthony Perera, the Manager of Akaa Family LLLP, exercises voting and dispositive power over the shares being offered under this prospectus. The address of Akaa Family LLLP is 1250 S. Pine Island Road, Suite 500, Plantation, FL 33323.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">(8)</TD>
    <TD STYLE="text-align: justify">Based upon information provided by Baja Portfolios LLC, Baja Portfolios LLC is the beneficial owner of Series B Preferred Stock at an aggregate principal amount of $50,000 convertible into 53,078 shares of Common Stock, and PIPE warrants to purchase up to 53,078 shares of Common Stock. Baja Portfolios LLC has a limitation on the amount of its beneficial ownership in the Securities Purchase Agreement with the Company pursuant to which Baja Portfolios LLC will not exercise its PIPE Warrants if, following such exercise, Baja Portfolios LLC would own more than 4.99% of the Company&rsquo;s issued and outstanding shares of Common Stock. Richard Steinberg, the Managing Manager of Baja Portfolios LLC, exercises voting and dispositive power over the shares being offered under this prospectus. The address of Baja Portfolios LLC is 205 E. 92nd Street, Suite 19G, New York, NY 10128.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">(9)</TD>
    <TD STYLE="text-align: justify">Based upon information provided by Eleven Ventures LLC, Eleven Ventures LLC is the beneficial owner of Series B Preferred Stock at an aggregate principal amount of $2,000,000 convertible into 2,123,142 shares of Common Stock, and PIPE warrants to purchase up to 2,123,142 shares of Common Stock. Eleven Ventures LLC has a limitation on the amount of its beneficial ownership in the Securities Purchase Agreement with the Company pursuant to which Eleven Ventures LLC will not exercise its PIPE Warrants if, following such exercise, Eleven Ventures LLC would own more than 4.99% of the Company&rsquo;s issued and outstanding shares of Common Stock. Hartley Yale Wasko, the CEO of Eleven Ventures LLC, exercises voting and dispositive power over the shares being offered under this prospectus. The address of Eleven Ventures LLC is 463 Adams Street, Denver, CO 80206.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">(10)</TD>
    <TD STYLE="text-align: justify">Based upon information provided by Francis Ong, Francis Ong is the beneficial owner of Series B Preferred Stock at an aggregate principal amount of $100,000 convertible into 106,157 shares of Common Stock, and PIPE warrants to purchase up to 106,157 shares of Common Stock. Francis Ong has a limitation on the amount of his beneficial ownership in the Securities Purchase Agreement with the Company pursuant to which Mr. Ong will not exercise his PIPE Warrants if, following such exercise, Mr. Ong would own more than 4.99% of the Company&rsquo;s issued and outstanding shares of Common Stock. The securities are directly held by Francis Ong. The address of Francis Ong is 1907 Clintonville Street, Whitestone, NY 11357.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.35in">(11)</TD>
    <TD STYLE="text-align: justify">Based upon information provided by Jim McCabe, Jim McCabe is the beneficial owner of Series B Preferred Stock at an aggregate principal amount of $500,000 convertible into 530,786 shares of Common Stock, and PIPE warrants to purchase up to 530,786 shares of Common Stock. Jim McCabe has a limitation on the amount of his beneficial ownership in the Securities Purchase Agreement with the Company pursuant to which Mr. McCabe will not exercise his PIPE Warrants if, following such exercise, Mr. McCabe would own more than 4.99% of the Company&rsquo;s issued and outstanding shares of Common Stock. The securities are directly held by Jim McCabe. The address of Jim McCabe is 1907 Clintonville Street, Whitestone, NY 11357.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>(12)</TD>
    <TD STYLE="text-align: justify">Based upon information provided by Tiger Capital Puerto Rico LLC, Tiger Capital Puerto Rico LLC is the beneficial owner of Series B Preferred Stock at an aggregate principal amount of $100,000 convertible into 106,157 shares of Common Stock, and PIPE warrants to purchase up to 106,157 shares of Common Stock. Tiger Capital Puerto Rico LLC has a limitation on the amount of its beneficial ownership in the Securities Purchase Agreement with the Company pursuant to which Tiger Capital Puerto Rico LLC will not exercise its PIPE Warrants if, following such exercise, Tiger Capital Puerto Rico LLC would own more than 4.99% of the Company&rsquo;s issued and outstanding shares of Common Stock. Alan Masley, the Managing Member of Tiger Capital Puerto Rico LLC, exercises voting and dispositive power over the shares being offered under this prospectus. The address of Tiger Capital Puerto Rico LLC is 1357 Ashford Ave, Suite 2-267, San Juan, PR 00907.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>(13)</TD>
    <TD STYLE="text-align: justify">Based upon information provided by Turnpoint Capital LLC, Turnpoint Capital LLC is the beneficial owner of Series B Preferred Stock at an aggregate principal amount of $150,000 convertible into 159,236 shares of Common Stock, and PIPE warrants to purchase up to 159,236 shares of Common Stock. Turnpoint Capital LLC has a limitation on the amount of its beneficial ownership in the Securities Purchase Agreement with the Company pursuant to which Turnpoint Capital LLC will not exercise its PIPE Warrants if, following such exercise, Turnpoint Capital LLC would own more than 4.99% of the Company&rsquo;s issued and outstanding shares of Common Stock. Daniel Schmidt, the CIO of Turnpoint Capital LLC, exercises voting and dispositive power over the shares being offered under this prospectus. The address of Turnpoint Capital LLC is 16 Banksville Road, Armonk, NY 10504.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>(14) &nbsp;</TD>
    <TD STYLE="text-align: justify">Based upon information provided by William Moreno, William Moreno is the beneficial owner of Series B Preferred Stock at an aggregate principal amount of $75,000 convertible into 79,618 shares of Common Stock, and PIPE warrants to purchase up to 79,618 shares of Common Stock. William Moreno has a limitation on the amount of his beneficial ownership in the Securities Purchase Agreement with the Company pursuant to which Mr. Moreno will not exercise his PIPE Warrants if, following such exercise, Mr. Moreno would own more than 4.99% of the Company&rsquo;s issued and outstanding shares of Common Stock. The securities are directly held by Mr. Moreno. The address of William Moreno is P.O. Box 198, Laurel, NY 11948.</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_010"></A>DESCRIPTION OF CAPITAL STOCK</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following summary of the rights of our capital
stock is not complete and is subject to and qualified in its entirety by reference to our Certificate of Incorporation, as amended (&ldquo;Certificate
of Incorporation&rdquo;), and Second Amended and Restated Bylaws (&ldquo;Bylaws&rdquo;), copies of which are filed as exhibits to our
Annual Report filed with the SEC on May 7, 2025, and the forms of securities, copies of which are filed as exhibits to the registration
statement of which this prospectus forms a part, which are incorporated by reference herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>General</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of the date of this prospectus, the Company&rsquo;s
common stock, par value $0.0001 is the only class of securities currently registered under Section 12 of the Exchange Act. Our Common
Stock is listed on the Nasdaq Capital Market under the symbol &ldquo;TBH.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company is authorized to issue an aggregate of 275,000,000&nbsp;shares
of capital stock. The authorized capital stock is divided into 250,000,000&nbsp;shares of common stock having a par value of $0.0001 per
share and 25,000,000&nbsp;shares of preferred stock having a par value of $0.0001 per share, of which 15,000 shares are designated as
the Series B Convertible Preferred Stock. As of August 4, 2025, there were 10,822,588 shares of Common Stock issued and outstanding and
15,000 shares of Series B Convertible Preferred Stock issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All shares of Common Stock of the Company are
one and the same class, identical in all respects and have equal rights, powers and privileges.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Voting. </I></B>Except
as otherwise provided for by resolution of the board of directors, the holders of outstanding shares of Common Stock have the
exclusive right to vote on all matters requiring stockholder action. On each matter on which holders of Common Stock are entitled
to vote, each outstanding share of such Common Stock is entitled to one vote. Under our second amended and restated bylaws, any
corporate action to be taken by vote of stockholders other than for election of directors shall be authorized by the affirmative
vote of the majority of votes cast. Directors are elected by a plurality of the votes cast, which means the nominees receiving the
highest number of &ldquo;for&rdquo; votes are elected. Stockholders do not have cumulative voting rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Dividends. </I></B>Subject to the
rights of holders of any series of outstanding preferred stock, holders of shares of Common Stock have equal rights of
participation in the dividends and other distributions in cash, stock or property of the Company when, as and if declared thereon by
the board of directors from time to time out of assets or funds of the Company legally available therefor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Liquidation.&nbsp;</I></B>Subject to the
rights of holders of any series of outstanding preferred stock, holders of shares of Common Stock have equal rights to receive the
assets and funds of the Company available for distribution to stockholders in the event of any liquidation, dissolution or winding up
of the affairs of the Company, whether voluntary or involuntary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Rights and Preferences.&nbsp;</I></B>Holders
of our Common Stock have no preemptive, conversion or subscription rights, and there are no redemption or sinking funds provisions
applicable to our Common Stock. The rights, preferences and privileges of the holders of our Common Stock are subject to, and may
be adversely affected by, the rights of the holders of shares of any series of our preferred stock that we may designate and issue in
the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Fully Paid and Nonassessable.&nbsp;</I></B>All
of our outstanding shares of Common Stock are fully paid and nonassessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">the redemption or repurchase rights and price or prices, if
any, for shares of the series;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We could issue a series of preferred stock that
could, depending on the terms of the series, impede or discourage an acquisition attempt or other transaction that some, or a majority,
of the holders of our common stock might believe to be in their best interests or in which the holders of our common stock might receive
a premium over the market price of the shares of our common stock. Additionally, the issuance of preferred stock may adversely affect
the rights of holders of our common stock by restricting dividends on the common stock, diluting the voting power of the common stock
or subordinating the liquidation rights of the common stock. As a result of these or other factors, the issuance of preferred stock could
have an adverse impact on the market price of our common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Description of Series B Convertible Preferred
Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Stated Value</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The stated value of the Series
B Convertible Preferred Stock shall be $1,000 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Dividend Rights</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Holders shall be entitled
to receive, and the Corporation shall pay, dividends on shares of Series B Preferred Stock equal (on an as-if-converted-to-Common-Stock
basis) to and in the same form as dividends actually paid on shares of the Common Stock when, as and if such dividends are paid on shares
of the Common Stock. No other dividends shall be paid on shares of Series B Preferred Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Voting Rights</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Holders of Series B Preferred
Stock shares are not entitled to any voting rights other than any vote required by law or the Company&rsquo;s Certificate of Incorporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Anti-Takeover Effects of Delaware law and
Our Certificate of Incorporation and Bylaws</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Certificate of Incorporation, Bylaws and
the Delaware General Corporation Law (the &ldquo;DGCL&rdquo;) contain provisions that are intended to enhance the likelihood of continuity
and stability in the composition of our Board. These provisions are intended to avoid costly takeover battles, reduce our vulnerability
to a hostile or abusive change of control and enhance the ability of our Board to maximize stockholder value in connection with any unsolicited
offer to acquire us. However, these provisions may have an anti-takeover effect and may delay, deter or prevent a merger or acquisition
of our company by means of a tender offer, a proxy contest or other takeover attempt that a stockholder might consider in its best interest,
including those attempts that might result in a premium over the prevailing market price for the shares of common stock held by stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Section 203 of the Delaware General Corporation
Law</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are subject to Section 203 of the DGCL, which
prohibits a Delaware corporation from engaging in any business combination with any interested stockholder for a period of three years
after the date that such stockholder became an interested stockholder, with the following exceptions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">before such date, the board of directors of the corporation
approved either the business combination or the transaction that resulted in the stockholder becoming an interested stockholder;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">upon completion of the transaction that resulted in the stockholder
becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding
at the time the transaction began, excluding for purposes of determining the voting stock outstanding (but not the outstanding voting
stock owned by the interested stockholder) those shares owned (i) by persons who are directors and also officers and (ii) employee stock
plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be
tendered in a tender or exchange offer; or</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">on or after such date, the business combination is approved
by the board of directors and authorized at an annual or special meeting of the stockholder, and not by written consent, by the affirmative
vote of at least 66 2/3% of the outstanding voting stock that is not owned by the interested stockholder.</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In general, Section 203 defines business combination
to include the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">any merger or consolidation involving the corporation and
the interested stockholder;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">any merger or consolidation involving the corporation and
the interested stockholder;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">subject to certain exceptions, any transaction that results
in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">any transaction involving the corporation that has the effect
of increasing the proportionate share of the stock or any class or series of the corporation beneficially owned by the interested stockholder;
or</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">the receipt by the interested stockholder of the benefit of
any loss, advances, guarantees, pledges or other financial benefits by or through the corporation.</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In general, Section 203 defines an &ldquo;interested
stockholder&rdquo; as an entity or person who, together with the person&rsquo;s affiliates and associates, beneficially owns, or within
three years prior to the time of determination of interested stockholder status did own, 15% or more of the outstanding voting stock
of the corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Potential Effects of Authorized but Unissued
Stock</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to our Certificate of Incorporation, we have shares of common stock and preferred stock available for future issuance without
stockholder approval. We may utilize these additional shares for a variety of corporate purposes, including future public offerings to
raise additional capital, to facilitate corporate acquisitions or payment as a dividend on the capital stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The existence of unissued and unreserved common
stock and preferred stock may enable our Board to issue shares to persons friendly to current management or to issue preferred stock
with terms that could render more difficult or discourage a third-party attempt to obtain control of us by means of a merger, tender
offer, proxy contest or otherwise, thereby protecting the continuity of our management. In addition, our Board has the discretion to
determine designations, rights, preferences, privileges and restrictions, including voting rights, dividend rights, conversion rights,
redemption privileges and liquidation preferences of each series of preferred stock, all to the fullest extent permissible under the
DGCL and subject to any limitations set forth in our Certificate of Incorporation. The purpose of authorizing our Board to issue preferred
stock and to determine the rights and preferences applicable to such preferred stock is to eliminate delays associated with a stockholder
vote on specific issuances. The issuance of preferred stock, while providing desirable flexibility in connection with possible financings,
acquisitions and other corporate purposes, could have the effect of making it more difficult for a third-party to acquire, or could discourage
a third-party from acquiring, a majority of our outstanding voting stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Transfer Agent and Registrar</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The transfer agent and registrar for our common
stock is VStock Transfer, LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>National Securities Exchange Listing</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our common stock is currently listed on Nasdaq
under the symbol &ldquo;TBH.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_011"></A>PLAN OF DISTRIBUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Stockholders and any of their pledgees, assignees or other
successors-in-interest may, from time to time, sell any or all of their shares of Common Stock or interests in shares of Common Stock
on any stock exchange, market or trading facility on which the shares are traded or in private transactions. These sales may be at fixed
prices or negotiated prices. The Selling Stockholders may use one or more of the following methods when disposing of the shares or interests
therein:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">ordinary brokerage transactions and transactions in which
the broker-dealer solicits purchasers;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">block trades in which the broker-dealer will attempt to sell
the securities as agent but may position and resell a portion of the block as principal to facilitate the transaction;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">purchases by a broker-dealer as principal and resale by the
broker-dealer for its account;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">an exchange distribution in accordance with the rules of the
applicable exchange;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">privately negotiated transactions;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">settlement of short sales;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">through the writing or settlement of options or other hedging
transactions, whether through an options exchange or otherwise;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">broker-dealers may agree with the Selling Stockholders to
sell a specified number of such shares at a stipulated price per security;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">a combination of any such methods of sale; and</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">any other method permitted pursuant to applicable law.</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Stockholders
may also sell shares under Rule 144 or Rule 904 under the Securities Act, if available, or Section 4(a)(1) under the Securities Act,
rather than under this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Broker-dealers engaged by
the Selling Stockholders may arrange for other broker-dealers to participate in sales. Broker-dealers may receive commissions or discounts
from the Selling Stockholders (or, if any broker-dealer acts as agent for the purchaser of shares, from the purchaser) in amounts to
be negotiated. The Selling Stockholders do not expect these commissions and discounts to exceed what is customary in the types of transactions
involved.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Stockholders
may, from time to time, pledge or grant a security interest in some or all of the shares of Common Stock owned by them and, if they default
in the performance of their secured obligations, the pledgees or secured parties may offer and sell shares of Common Stock from time
to time under this prospectus, or under a supplement or amendment to this prospectus under Rule 424(b)(3) or other applicable provision
of the Securities Act amending the list of Selling Stockholders to include the pledgee, transferee or other successors in interest as
Selling Stockholders under this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon being notified in writing
by a Selling Stockholder that any material arrangement has been entered into with a broker-dealer for the sale of Common Stock through
a block trade, special offering, exchange distribution or secondary distribution or a purchase by a broker or dealer, we will file a
supplement to this prospectus, if required, pursuant to Rule 424(b) under the Securities Act, disclosing (i) the name of each such Selling
Stockholder and of the participating broker-dealer(s), (ii) the number of shares involved, (iii) the price at which such shares of Common
Stock were sold, (iv) the commissions paid or discounts or concessions allowed to such broker-dealer(s), where applicable, (v) that such
broker-dealer(s) did not conduct any investigation to verify the information set out or incorporated by reference in this prospectus
and (vi) other facts material to the transaction. In addition, upon being notified in writing by a Selling Stockholder that a donee or
pledgee intends to sell more than 500 shares of Common Stock, we will file a supplement to this prospectus, if then required in accordance
with applicable securities law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Stockholders
also may transfer the shares of Common Stock in other circumstances, in which case the transferees, pledgees or other successors in interest
will be the selling beneficial owners for purposes of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the sale
of the shares of Common Stock or interests in shares of Common Stock, the Selling Stockholders may enter into hedging transactions with
broker-dealers or other financial institutions, which may in turn engage in short sales of the Common Stock in the course of hedging
the positions they assume. The Selling Stockholders may also sell shares of Common Stock short and deliver these securities to close
out their short positions, or loan or pledge the Common Stock to broker-dealers that in turn may sell these securities. The Selling Stockholders
may also enter into option or other transactions with broker-dealers or other financial institutions or the creation of one or more derivative
securities which require the delivery to such broker-dealer or other financial institution of shares offered by this prospectus, which
shares such broker-dealer or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect
such transaction).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Stockholders
and any broker-dealers or agents that are involved in selling the shares may be deemed to be &ldquo;underwriters&rdquo; within the meaning
of the Securities Act in connection with such sales. In such event, any profits realized by such Selling Stockholders or compensation
received by such broker-dealers or agents may be deemed to be underwriting commissions or discounts under the Securities Act. The maximum
commission or discount to be received by any member of the Financial Industry Regulatory Authority (FINRA) or independent broker-dealer
will not be greater than 8% of the initial gross proceeds from the sale of any security being sold.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The aggregate proceeds to
the Selling Stockholders from the sale of the Common Stock offered by them will be the purchase price of the Common Stock less discounts
or commissions, if any. Each of the Selling Stockholders reserves the right to accept and, together with their agents from time to time,
to reject, in whole or in part, any proposed purchase of Common Stock to be made directly or through agents. We will not receive any
of the proceeds from this offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are required to pay all
fees and expenses incident to the registration of the shares. We have agreed to indemnify the Selling Stockholders against certain losses,
claims, damages and liabilities, including liabilities under the Securities Act or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_012"></A>INFORMATION INCORPORATED BY REFERENCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The SEC allows us to &ldquo;incorporate by reference&rdquo;
information that we file with it into this prospectus, which means that we can disclose important information to you by referring you
to those documents. The information incorporated by reference is an important part of this prospectus. The information incorporated by
reference is considered to be a part of this prospectus, and information that we file later with the SEC will automatically update and
supersede information contained in this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We incorporate by reference the following documents
or information that we have filed with the SEC:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in">&#9679;</TD>
    <TD STYLE="text-align: justify">our Annual Report on <A HREF="https://www.sec.gov/Archives/edgar/data/1903595/000121390025040732/ea0236064-10k_brag.htm">Form 10-K</A> for the year ended December 31, 2024 filed with the SEC on May 7,
    2025.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&#9679;</TD>
    <TD STYLE="text-align: justify">our Quarterly Report on <A HREF="https://www.sec.gov/Archives/edgar/data/1903595/000121390025065688/ea0248572-10q_brag.htm">Form 10-Q</A> for the quarterly period ended March 31, 2025 filed with the SEC
    on July 18, 2025.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&#9679;</TD>
    <TD STYLE="text-align: justify">our Current Reports on Form 8-K filed with the SEC on <A HREF="https://www.sec.gov/Archives/edgar/data/1903595/000121390025043037/ea0242102-8k_braghouse.htm">May 14, 2025</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1903595/000121390025044929/ea024260201-8k_braghouse.htm">May 16, 2025</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1903595/000121390025049498/ea024405201-8k_braghouse.htm">May 30, 2025</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1903595/000121390025054411/ea0245708-8k_braghouse.htm">June 16, 2025</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1903595/000121390025057825/ea024697301-8k_braghouse.htm">June 25, 2025</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1903595/000121390025066339/ea0249804-8k_brag.htm">July 22, 2025</A>, and <A HREF="https://www.sec.gov/Archives/edgar/data/1903595/000121390025069378/ea0250726-8k_brag.htm">July 30, 2025</A>.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All other reports and documents filed by us pursuant
to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act after the date that this registration statement becomes effective and after
the date of this prospectus but before the termination of the offering of the securities described in this prospectus shall be deemed
to be incorporated by reference into this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding the statements in the preceding
paragraphs, no document, report or exhibit (or portion of any of the foregoing) or any other information that we have &ldquo;furnished&rdquo;
to the SEC pursuant to the Exchange Act shall be incorporated by reference into this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any statement contained in this prospectus or
contained in a document incorporated or deemed to be incorporated by reference into this prospectus will be deemed to be modified or
superseded to the extent that a statement contained in this prospectus or any subsequently filed supplement to this prospectus, or document
deemed to be incorporated by reference into this prospectus, modifies or supersedes such statement. Any statements so modified or superseded
shall not be deemed, except as so modified or superseded, to constitute a part of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You may request a copy of these filings at no
cost, by writing or telephoning us at the following address:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Brag House Holdings Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Attn: Lavell Juan Malloy, II</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Chief Executive Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">45 Park Street</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Montclair, NJ 07042</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Telephone: (413) 398-2845</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You may also access these filings on our website
at www.braghouse.com. You should rely only on the information incorporated by reference or provided in this prospectus. We have not authorized
anyone else to provide different or additional information on our behalf. An offer of these securities is not being made in any jurisdiction
where the offer or sale is not permitted. You should not assume that the information in this prospectus is accurate as of any date other
than the date of those respective documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_013"></A>WHERE YOU CAN FIND MORE INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus is part of a registration statement
we filed with the SEC. This prospectus does not contain all of the information set forth in the registration statement and the exhibits
to the registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For further information with respect to us and
the securities we are offering under this prospectus, we refer you to the registration statement and the exhibits and schedules filed
as a part of the registration statement. You should rely only on the information contained in this prospectus or incorporated by reference
into this prospectus. We have not authorized anyone else to provide you with different information. We are not making an offer of these
securities in any jurisdiction where the offer is not permitted. You should assume that the information contained in this prospectus,
or any document incorporated by reference in this prospectus, is accurate only as of the date of those respective documents, regardless
of the time of delivery of this prospectus or any sale of our securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We file annual, quarterly and current reports,
proxy statements and other information with the SEC. Our SEC filings are available to the public from commercial document retrieval services
and over the Internet at the SEC&rsquo;s website at http://www.sec.gov.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We maintain a website at www.braghouse.com. You
may access our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to those reports
filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act with the SEC free of charge at our website as soon as reasonably
practicable after such material is electronically filed with, or furnished to, the SEC. The information contained in, or that can be
accessed through, our website is not incorporated by reference into, and is not part of, this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><A NAME="a_014"></A>LEGAL MATTERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Lucosky Brookman LLP serves
as our legal counsel in connection with this offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><A NAME="a_015"></A>EXPERTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The audited annual consolidated financial statements
of Brag House Holdings, Inc. incorporated by reference in this prospectus and elsewhere in the registration statement have been incorporated
by reference in reliance upon the report of Marcum LLP, our former independent registered public accounting firm, which includes an explanatory
paragraph as to our ability to continue as a going concern, upon the authority of said firm as experts in accounting and auditing. The
2024 and 2023 audited annual consolidated financial statements of Brag House Holdings, Inc. as of and for the years ended December 31,
2024 and 2023, have been audited by Marcum LLP, our former independent registered public accounting firm.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="image_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Up to 32,904,677 Shares of Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The date of this prospectus is&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; , 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PART II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: center"><B>INFORMATION NOT REQUIRED IN PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 13. Other Expenses of Issuance and Distribution.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">The following table sets forth the costs and
expenses, other than placement agent fees and commissions, payable by us in connection with the sale and distribution of the securities
being registered. All of the amounts shown are estimates, except for the SEC registration fee:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amount <BR> to be paid</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: left">SEC registration fee</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">5,793.36</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Legal fees and expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">35,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Accounting fees and expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total expenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">65,793.36</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 14. Indemnification of Directors and
Officers.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">Section 102 of the DGCL permits a corporation
to eliminate the personal liability of directors and officers of a corporation to the corporation or its stockholders for monetary damages
for a breach of fiduciary duty as a director or officer, except where the director breached his duty of loyalty, failed to act in good
faith, engaged in intentional misconduct or knowingly violated a law, obtained an improper personal benefit, in the case of a director,
authorized the payment of a dividend or approved a stock repurchase in violation of Delaware corporate law, or in the case of an officer,
a breach of fiduciary duty in any action by or in the right of the corporation. Our Certificate of Incorporation provides that no director
or officer shall be personally liable to it or its stockholders for monetary damages for any breach of fiduciary duty as a director or
officer to the fullest extent permitted by the DGCL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">Section 145 of the DGCL provides that a corporation
has the power to indemnify a director, officer, employee, or agent of the corporation, or a person serving at the request of the corporation
for another corporation, partnership, joint venture, trust or other enterprise in related capacities against expenses (including attorneys&rsquo;
fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by the person in connection with an action, suit
or proceeding to which he was or is a party or is threatened to be made a party to any threatened, ending or completed action, suit or
proceeding by reason of such position, if such person acted in good faith and in a manner he reasonably believed to be in or not opposed
to the best interests of the corporation, and, in any criminal action or proceeding, had no reasonable cause to believe his conduct was
unlawful, except that, in the case of actions brought by or in the right of the corporation, no indemnification shall be made with respect
to any claim, issue or matter as to which such person shall have been adjudged to be liable to the corporation unless and only to the
extent that the Court of Chancery or other adjudicating court determines that, despite the adjudication of liability but in view of all
of the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which the Court of Chancery
or such other court shall deem proper.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">Our certificate of incorporation and second amended
and restated bylaws provide for indemnification of directors and officers to the fullest extent permitted by law, including payment of
expenses in advance of resolution of any such matter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">We intend to enter into separate indemnification
agreements with our directors and officers. Each indemnification agreement will provide, among other things, for indemnification to the
fullest extent permitted by law and our certificate of incorporation and second amended and restated bylaws against any and all expenses,
judgments, fines, penalties and amounts paid in settlement of any claim. The indemnification agreements will provide for the advancement
or payment of all expenses to the indemnitee and for reimbursement to us if it is found that such indemnitee is not entitled to such
indemnification under applicable law and our certificate of incorporation and second amended and restated bylaws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 28; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">We are in the process of obtaining standard policies
of insurance under which coverage is provided (a)&nbsp;to our directors and officers against loss rising from claims made by reason of
breach of duty or other wrongful act, and (b)&nbsp;to us with respect to payments which we may make to such officers and directors pursuant
to the above indemnification provision or otherwise as a matter of&nbsp;law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">Insofar as indemnification for liabilities arising
under the Securities Act may be permitted to directors, officers or persons controlling us under the foregoing provisions, we have been
informed that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is therefore
unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 15. Recent Sales of Unregistered Securities.
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I></I></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">During the past three&nbsp;years, we issued the
following securities, which were not registered under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Original Issue Discount Convertible Promissory
Notes</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From 2022 through 2024, the Company issued convertible
debt in the form of original issue discount convertible promissory notes. These notes provided investors with a 20% discount on their
investment amount. A total of $2,288,884 was received by the Company as of May of 2024 with a total discount of $572,221, resulting in
the issuance of notes with an original principal amount of $2,861,105. The original principal balance was then further increased due to
loan extensions fees totaling $2,861,406 - which resulted in a total principal amount due to noteholders at December 31, 2024 of $5,722,511.
A total of $888,893 was accrued in interest through 2024. In addition, the note holders were issued a total of 76,110 shares of Common
Stock as settlement of equity kicker shares that were due to investors for amounts totaling $186,775.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All of these notes from 2022 through 2024 were
converted into shares of Common Stock in March of 2025 following the closing of our IPO. The note holders were issued a total of 1,912,176
shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">An additional accrual of interest through the
date of the IPO, March 7, 2025, was recorded as of March 7, 2025 for $103,101 to be converted into 29,660 shares of Common Stock. In April
of 2025, 29,305 of these shares were granted. The remaining 355 shares are pending to be issued and the balance of the accrued interest
for the shares that were not yet granted, $1,234, is recorded as a share payable balance until granted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Original Issue Discount Convertible Promissory
Note - December 2024</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In December of 2024, the Company raised $25,000
from a short-term promissory note which has a 30% original issue discount that constitutes the interest due on the loan and was added
to the principal balance, a payment in equity kicker shares of the Company&rsquo;s Common Stock having a combined value equaling 30% of
the principal amount and a maturity date of February 15, 2025. The number of the shares subject to the equity kicker were calculated based
on the Company&rsquo;s price per share at the IPO, which was at $4.00 per share. This resulted in shares payable of 1,875, which are valued
at $4.00 per share as of the issuance date These shares were issued in April of 2025, subsequent to the maturity date of February 15,
2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Similar to this loan, the Company raised an additional
$150,000 from two short-term promissory notes during 2025 which have a 30% original issue discount that constitutes the interest due on
the loan and was added to the principal balance, a payment in equity kicker shares of the Company&rsquo;s Common Stock having a combined
value equaling 30% of the principal amount and a maturity date of April 10, 2025. The number of the shares subject to the equity kicker
were calculated based on the Company&rsquo;s anticipated price per share at the IPO, which was at $4. The original issue discount and
the equity kicker shares had values of $45,000 each for a total discount on debt of $90,000. The issuance of this loan resulted in an
additional 11,250 shares of Common Stock becoming due. As such, it resulted in an increase of $45,000 to the shares payable balance in
2025. These shares were issued in April of 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Marketing Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In March of 2025, the Company executed a modification
of the existing marketing agreement with Outside the Box Capital to revise the terms. This new agreement revised the dates of service
to begin on March 6, 2025 through September 6, 2025. As a result, the base compensation is expected to be $100,000 which will be payable
in two tranches, the first payment for $50,000 within 10 business days following the Company&rsquo;s listing date as a publicly traded
company (&ldquo;Listing Date&rdquo;) and the second and final payment for the remaining amount will be due three months from the Listing
Date. The first payment of $50,000 was made in April of 2025, subsequent to the due date of March 20, 2025. Additionally, $200,000 worth
of the Company&rsquo;s Common Stock, priced at the Company&rsquo;s IPO price of $4.00 per share became due within ten business days of
the Listing Date. The Company issued the shares in April of 2025, subsequent to the due date of March 20, 2025. Lastly, 50,000 additional
Common Stock shares will be issued as an earnout tranche if, within the terms of the agreement, the Company&rsquo;s shares achieve a seven
day moving average (calculated using daily VWAP) share price of $9 or higher. The shares would be due within 10 days following the achievement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>2024 Stock Issuances</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 22, 2024, the Company sold 29,094&nbsp;shares
of BHHI common stock for total proceeds of $100,000 (as adjusted for the Reverse Stock Split).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 26, 2024, the Company sold 6,250&nbsp;shares
of common stock (as adjusted for the Reverse Stock Split) for total cash proceeds of $25,000. The shares of common stock were issued immediately
after the consummation of our IPO, in accordance with the subscription agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In March of 2025, the Company&rsquo;s Board of
Directors issued their unanimous consent to issue shares in connection with several transactions and the Company issued those shares.
The Company authorized and issued 56 shares of Common Stock owed following the effecting of the Reverse Stock Split by the Company&rsquo;s
transfer agent in January of 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Lastly, in March of 2025, the Company authorized
and issued 82,096 shares of Common Stock due to the conversion of each share of series A convertible preferred stock to one share of Common
Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Shares Payable</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In May of 2025, the Company issued 59,746 shares
of Common Stock in connection with payment to several contractors for services totaling $164,630.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Notes Payable</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During August and September of 2024, the Company
raised $280,000 in short-term loans that are expected to be repaid within a year, although a maturity date is not specified. These loans
have a 100% interest fee that is due at the date of repayment and an additional 100% fee in shares of the Company&rsquo;s Common Stock
issued at the current fair market value, which was $1.41 at the dates of the loans. In September of 2024, the Company issued 198,454
shares of Common Stock in full payment of the $280,000 amount that was payable in shares of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Artemis Stock Consideration and EVEMeta Stock
Consideration</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 13, 2024 (the &ldquo;Artemis Effective
Date&rdquo;), Brag House entered into the MSA with Artemis, a technology company focused on B2B2C solution for engagement, streaming,
and gaming, whereby Artemis agreed to develop, and the Company agreed to purchase, a proprietary machine learning solution for our platform,
in exchange for the Artemis Stock Consideration. The Artemis Stock Consideration was issued to Artemis in December 2024, (as adjusted
for the Reverse Stock Split), and is subject to a lock-up&nbsp;provision, with the shares of the Artemis Stock Consideration to be released
in three (3) equal tranches of 312,500&nbsp;shares each according to the terms outlined in the MSA and the respective SOWs attached thereto.
In the event that Artemis seeks to sell the shares of the Artemis Stock Consideration on a given day when the then-applicable&nbsp;closing
price of such shares is less than the Target Sale Price and Artemis actually sold such shares at a price below the Target Sale Price,
the Company agreed to pay Artemis the difference between the Target Sale Price and the actual price per share it receives in respect of
such sale up to an aggregate amount equal to $3,750,000, subject to certain other conditions, thus providing a guarantee of a minimum
value. This guarantee is only in effect for a period of time and, in any event, if Artemis does not liquidate all of the Artemis Stock
Consideration within 18&nbsp;months of release of each corresponding lock-up, the minimum value guarantee will no longer be in effect.
Subsequently, on May 12, 2025, the Company executed an amendment to the MSA with Artemis that eliminated this guarantee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Additionally, on November 13, 2024 (the &ldquo;EVEMeta
Effective Date&rdquo;), Brag House entered into the SaaS Agreement with EVEMeta, whereby EVEMeta agreed to license its solution to the
Company, and the Company agreed to issue the EVEMeta Stock Consideration. The EVEMeta Stock Consideration was issued to EVEMeta in December
2024 (as adjusted for the Reverse Stock Split) and is subject to a lock-up&nbsp;provision, with the shares of EVEMeta Stock Consideration
to be released in accordance with the terms outlined in the SaaS Agreement. In the event that EVEMeta seeks to sell the shares of the
EVEMeta Stock Consideration on a given day when the then-applicable&nbsp;closing price of such shares is less than the Target Sale Price
and EVEMeta actually sold such shares at a price below the Target Sale Price, the Company agreed to pay EVEMeta the difference between
the Target Sale Price and the actual price per share it receives in respect of such sale up to an aggregate amount equal to $1,250,000,
subject to certain other conditions, thus providing a guarantee of a minimum value. This guarantee is only in effect for a period of time
and, in any event, if EVEMeta does not liquidate all of the EVEMeta Stock Consideration within 18&nbsp;months of release of each corresponding
lock-up, the minimum value guarantee will no longer be in effect. Subsequently, on May 12, 2025, the Company executed an amendment to
the SaaS Agreement with EVEMeta that eliminated this guarantee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The offer and sale of all securities listed in
this item 15 was made to a limited number of accredited investors and qualified institutional buyers in reliance upon exemptions from
the registration requirements pursuant to Section 4(a)(2) under the Securities Act and Regulation D promulgated under the Securities Act.
Individuals who purchased securities as described above represented their intention to acquire the securities for investment only and
not with a view to or for sale in connection with any distribution thereof, and appropriate legends were affixed to the share certificates
issued in such transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 16. Exhibits.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 9%"><B>EXHIBIT</B></TD>
    <TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 90%"><B>DESCRIPTION</B></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.25pt">3.1</TD>
    <TD STYLE="padding-bottom: 2.25pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1903595/000121390024053492/ea020493001ex3-1_brag.htm">Certificate of Incorporation of Brag House Holdings, Inc. (incorporated by reference to Exhibit 3.1 of the Company&rsquo;s Form S-1 (File No. 333-280282) filed with the SEC on June 18, 2024).</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt">3.2</TD>
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1903595/000121390024060509/ea020493002ex3-2_braghouse.htm">Certificate of Designation of Series A Convertible Preferred Stock (incorporated by reference to Exhibit 3.2 of the Company&rsquo;s Form S-1/A (File No. 333-280282) filed with the SEC on July 10, 2024).</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt">3.3</TD>
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1903595/000121390024053492/ea020493001ex3-2_brag.htm">Certificate of Amendment to Certificate of Incorporation of Brag House Holdings, Inc. (incorporated by reference to Exhibit 3.2 of the Company&rsquo;s Form S-1 (File No. 333-280282) filed with the SEC on June 18, 2024).</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt">3.4</TD>
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1903595/000121390024053492/ea020493001ex3-3_brag.htm">Second Certificate of Amendment to Certificate of Incorporation of Brag House Holdings, Inc. (incorporated by reference to Exhibit 3.3 of the Company&rsquo;s Form S-1 (File No. 333-280282) filed with the SEC on June 18, 2024).</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt">3.5</TD>
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1903595/000121390025009640/ea020493008ex3-5_brag.htm">Third Certificate of Amendment to Certificate of Incorporation of Brag House Holdings, Inc. (incorporated by reference to Exhibit 3.1 of the Company&rsquo;s Form S-1/A (File No. 333-280282) filed with the SEC on February 4, 2025).</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt">3.6</TD>
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1903595/000121390024053492/ea020493001ex3-4_brag.htm">Bylaws of Brag House Holdings, Inc. (incorporated by reference to Exhibit 3.4 of the Company&rsquo;s Form S-1 (File No. 333-280282) filed with the SEC on June 18, 2024).</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt">3.7</TD>
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1903595/000121390025012154/ea020493010ex3-7_brag.htm">Second Amended and Restated Bylaws of Brag House Holdings, Inc. (incorporated by reference to Exhibit 3.7 of the Company&rsquo;s Form S-1/A (File No. 333-280282) filed with the SEC on February 11, 2025).</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt">3.8</TD>
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1903595/000121390025069378/ea025072601ex3-1_brag.htm">Certificate of Designation of Series B Preferred Stock of Brag House Holdings, Inc. (incorporated by reference to Exhibit 3.1 of the Company&rsquo;s Current Report on Form 8-K filed with the SEC on July 30, 2025).</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt">5.1*</TD>
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt"><A HREF="ea025198001ex5-1_brag.htm">Opinion of Lucosky Brookman&nbsp;LLP</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt">10.1</TD>
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1903595/000121390025069378/ea025072601ex10-1_brag.htm">Securities Purchase Agreement, dated July 24, 2025, by and between Brag House Holdings, Inc. and twelve accredited investors (incorporated by reference to Exhibit 10.1 of the Company&rsquo;s Current Report on Form 8-K filed with the SEC on July 30, 2025).</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt">10.2</TD>
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1903595/000121390025069378/ea025072601ex10-2_brag.htm">Placement Agenct Agreement, dated July 24, 2025, by and between Brag House Holdings, Inc. and Revere Securities LLC (incorporated by reference to Exhibit 10.2 of the Company&rsquo;s Current Report on Form 8-K filed with the SEC on July 30, 2025).</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt">10.3</TD>
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1903595/000121390025069378/ea025072601ex10-3_brag.htm">Registration Rights Agreement, dated July 24, 2025, by and between Brag House Holdings, Inc. and twelve accredited investors (incorporated by reference to Exhibit 10.3 of the Company&rsquo;s Current Report on Form 8-K filed with the SEC on July 30, 2025).</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt">10.4*</TD>
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt"><A HREF="ea025198001ex10-4_brag.htm">Amendment to Placement Agent Agreement, dated July 31, 2025, by and between Brag House Holdings, Inc. and Revere Securities LLC.</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt">21.1</TD>
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1903595/000121390024060509/ea020493002ex21-1_braghouse.htm">Subsidiaries of the Registrant (incorporated by reference to Exhibit 21.1 of the Company&rsquo;s Form S-1/A (File No. 333-280282) filed with the SEC on July 10, 2024)</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt">23.1*</TD>
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt"><A HREF="ea025198001ex23-1_brag.htm">Consent of Independent Registered Public Accounting Firm (Marcum LLP)</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt">23.2*</TD>
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt"><A HREF="ea025198001ex5-1_brag.htm">Consent of Lucosky Brookman LLP (included in Exhibit 5.1)</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt">24.1*</TD>
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt"><A HREF="#p_001">Power of Attorney (included on signature page)</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-bottom: 2.25pt">107*</TD>
    <TD STYLE="padding-bottom: 2.25pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.25pt"><A HREF="ea025198001ex-fee_brag.htm">Filing Fee Table</A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left">*</TD><TD STYLE="text-align: justify">Filed herewith.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 17. Undertakings.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The undersigned registrant hereby undertakes</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(a) To file, during any period in which offers
or sales are being made, a post-effective amendment to this registration statement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(i) To include any prospectus required
by Section 10(a)(3) of the Securities Act;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(ii) To reflect in the prospectus any
facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof)
which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding
the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed
that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the
form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more
than 20 percent change in the maximum aggregate offering price set forth in the &ldquo;Calculation of Registration Fee&rdquo; table in
the effective registration statement; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(iii) To include any material information
with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information
in the registration statement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(b) that, for the purpose of determining any
liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to
the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial <I>bona fide</I> offering
thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(c) to remove from registration by means of a
post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(d) that, for the purpose of determining liability
under the Securities Act of 1933 to any purchaser, each prospectus filed pursuant to Rule 424(b) as part of a registration statement
relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule
430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. <I>Provided,
however</I>, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a
document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration
statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was
made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately
prior to such date of first use.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(e) that, for the purpose of determining liability
of the registrant under the Securities Act to any purchaser in the initial distribution of the securities, the undersigned registrant
hereby undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless
of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means
of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer
or sell such securities to such purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(i) Any preliminary prospectus or prospectus
of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424 (&sect; 230.424 of this chapter);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(ii) Any free writing prospectus relating
to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(iii) The portion of any other free
writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided
by or on behalf of the undersigned registrant; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(iv) Any other communication that is
an offer in the offering made by the undersigned registrant to the purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(f) Insofar as indemnification for liabilities
arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the Registrant pursuant to
the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the SEC such indemnification is against
public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities
(other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant
in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection
with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling
precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as
expressed in the Act and will be governed by the final adjudication of such issue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(g) That:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(1) For purposes of determining any
liability under the Securities Act of 1933, the information omitted from the form of prospectus filed as part of this registration statement
in reliance upon Rule 430A and contained in a form of prospectus filed by the Registrant pursuant to Rule 424(b)(1) or (4) or 497(h)
under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(2) For the purpose of determining
any liability under the Securities Act of 1933, each post-effective amendment that contains a form of prospectus shall be deemed to be
a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed
to be the initial bona fide offering thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the requirements of the Securities
Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly
authorized in the City of Brooklyn, State of New&nbsp;York, on this&nbsp;11<SUP>th</SUP>&nbsp;day of August, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding-right: 0pt; padding-left: 0pt; text-align: justify"><B>BRAG HOUSE HOLDINGS, INC.</B></TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; padding-right: 0pt; padding-left: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 4%; padding-right: 0pt; padding-left: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 36%; padding-right: 0pt; padding-left: 0pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-align: justify">Dated: August 11, 2025</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-align: justify">By:</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; padding-right: 0pt; padding-left: 0pt; text-align: justify"><I>/s/ Lavell Juan Malloy,
    II</I></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-align: justify">Lavell Juan Malloy, II</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-align: justify">Chief Executive Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="p_001"></A>POWER OF ATTORNEY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">We, the undersigned officers and directors of
Brag House Holdings, Inc., hereby severally constitute and appoint Lavell Juan Malloy, II and Chetan Jindal, and each of them singly
(with full power to each of them to act alone), to sign any and all amendments (including post-effective amendments) to this registration
statement (or any other registration statement for the same offering that is to be effective upon filing pursuant to Rule 462(b) under
the Securities Act of 1933), and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities
and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform
each and every act and thing requisite or necessary to be done in and about the premises, as full to all intents and purposes as he might
or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them, or their or his substitute
or substitutes, may lawfully do or cause to be done by virtue hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">Pursuant to the requirements of the Securities Act of 1933, this registration
statement has been signed by the following persons in the capacities held on the dates indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; padding: 0pt; width: 33%; text-align: center"><B>Signature</B></TD>
    <TD STYLE="padding: 0pt; width: 1%; text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; padding: 0pt; width: 45%; text-align: center"><B>Title</B></TD>
    <TD STYLE="padding: 0pt; width: 1%; text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; padding: 0pt; width: 20%; text-align: center"><B>Date</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-bottom: black 1.5pt solid; padding: 0pt; vertical-align: bottom; text-align: justify"><I>/s/
    Lavell Juan Malloy, II</I></TD>
    <TD STYLE="padding: 0pt; vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; vertical-align: top; text-align: justify">Chief Executive Officer and Director</TD>
    <TD STYLE="padding: 0pt; vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; vertical-align: top; text-align: justify">August 11, 2025</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0pt; text-align: justify">Lavell Juan Malloy, II</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">(Principal Executive Officer)</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-bottom: black 1.5pt solid; padding: 0pt; vertical-align: bottom; text-align: justify"><I>/s/
    Chetan Jindal</I></TD>
    <TD STYLE="padding: 0pt; vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; vertical-align: top; text-align: justify">Chief Financial Officer (Principal</TD>
    <TD STYLE="padding: 0pt; vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; vertical-align: top; text-align: justify">August 11, 2025</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0pt; text-align: justify">Chetan Jindal</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">Financial Officer and Principal Accounting Officer)</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; padding: 0pt; text-align: justify"><I>/s/ Daniel Leibovich</I></TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">Director</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">August 11, 2025</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0pt; text-align: justify">Daniel Leibovich</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; padding: 0pt; text-align: justify"><I>/s/ Kevin Foster</I></TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">Director</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">August 11, 2025</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0pt; text-align: justify">Kevin Foster</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; padding: 0pt; text-align: justify"><I>/s/ DeLu Jackson</I></TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">Director</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">August 11, 2025</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0pt; text-align: justify">DeLu Jackson</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; padding: 0pt; text-align: justify"><I>/s/ Daniel Fidrya</I></TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">Director</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">August 11, 2025</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0pt; text-align: justify">Daniel Fidrya</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 34; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>ea025198001ex5-1_brag.htm
<DESCRIPTION>OPINION OF LUCOSKY BROOKMAN LLP
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 5.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 49%">&nbsp;</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 49%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>LUCOSKY BROOKMAN LLP</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">101 Wood Avenue South</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">5th Floor</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Woodbridge, NJ 08830</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">T - (732) 395-4400</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">F- (732) 395-4401</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><IMG SRC="ex5-1_001.jpg" ALT=""></TD>
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">111 Broadway</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Suite 807</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">New York, NY 10006</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">T - (212) 417-8160</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">F - (212) 417-8161</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">www. lucbro.com</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">August 11, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Brag House Holdings, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">45 Park Street,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Montclair, NJ 07042&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>RE: Brag House Holdings, Inc.&rsquo;s Registration
Statement on Form S-1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have acted as counsel to you, Brag House Holdings,
Inc., a Delaware corporation, (the &ldquo;<U>Company</U>&rdquo;) in connection with the Company&rsquo;s Registration Statement on Form
S-1 filed with the Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;) pursuant to the Securities Act of 1933, as
amended (the &ldquo;<U>Securities Act</U>&rdquo;) on the date hereof (the &ldquo;<U>Registration Statement </U>&rdquo;). The Registration
Statement relates to the resale by certain selling stockholders of up to an aggregate of (i) up to 15,923,567 shares of the Company&rsquo;s
common stock, $0.0001 par value per share (the &ldquo;<U>Common Stock</U>&rdquo;) that may be issued from time to time upon conversion
of Series B Convertible Preferred Stock (the &ldquo;<U>Conversion Shares</U>&rdquo;) (ii) warrants (the &ldquo;<U>Warrants</U>&rdquo;),
to purchase up to an aggregate of 15,923,567 shares of Common Stock (the &ldquo;<U>Warrant Shares</U>&rdquo;), all in accordance with
that certain Securities Purchase Agreement, dated as of July 24, 2025 (the &ldquo;<U>Purchase Agreement</U>&rdquo;), by and among the
Company and the Purchasers named therein; and (iii) pursuant to that certain Placement Agency Agreement, dated July 24, 2025 (the &ldquo;<U>Placement
Agency Agreement</U>&rdquo;) warrants (the &ldquo;<U>Placement Agent Warrants</U>&rdquo;) to purchase up to an aggregate of 1,057,543
shares (the &ldquo;<U>Placement Agent Warrant Shares</U>&rdquo; and together with the Warrants, the Conversion Shares, the Warrant Shares,
and the Placement Agent Warrants, the &ldquo;<U>Securities</U>&rdquo;) of Common Stock (equal to 6.0% of 10,817,123 Conversion Shares
and 8.0% of 5,106,444 Conversion Shares sold in the offering) that the Company issued to Revere Securities LLC (the &ldquo;<U>Placement
Agent</U>&rdquo;) or its designees, as compensation in connection with the offering of the Series B Convertible Preferred Stock and the
Warrants. The Purchase Agreement, the Warrants, and the Placement Agent Warrants are referred to collectively herein as the &ldquo;<U>Transaction
Documents</U>&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This opinion is being furnished in accordance
with the requirements of Item 601(b)(5) of Regulation S-K under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with this opinion, we have examined
the originals or copies certified or otherwise identified to our satisfaction of the following: (a) the Articles of Incorporation, Amended
and Restated Bylaws of the Company, and Certificate of Designation of the Series B Convertible Preferred Stock, each as amended and/or
restated as of the date hereof; (b) certain resolutions of the Board of Directors of the Company related to the filing of the Registration
Statement, the authorization and issuance of the Securities, and related matters; (c) the Registration Statement and all exhibits thereto,
(d) the Transaction Documents; and (e) such other records, documents and instruments as we deemed relevant and necessary for purposes
of the opinion stated herein. In addition to the foregoing, we also have relied as to matters of fact upon the representations made by
the Company and its representatives and we have assumed the genuineness of all signatures, the authenticity of all documents submitted
to us as originals, and the conformity to original documents of all documents submitted to us certified or photostatic copies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based upon the foregoing and in reliance thereon,
and subject to the qualifications, limitations, exceptions and assumptions set forth herein, we are of the opinion that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">(i)</TD>
    <TD STYLE="padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify">the Conversion Shares have been duly authorized by all necessary corporate action of the Company, and when issued and delivered by the Company upon the conversion of the Series B Convertible Preferred Stock as set forth in the Registration Statement, will be validly issued, fully paid and non-assessable; and</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>(ii)</TD>
    <TD STYLE="text-align: justify">the Warrant Shares have been duly authorized, and when issued and delivered by the Company upon exercise of the Warrants in accordance with the terms of such Warrants, will be validly issued, fully paid and non-assessable.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>(iii)</TD>
    <TD STYLE="text-align: justify">the Placement Agent Warrant Shares have been duly authorized, and when issued and delivered by the Company upon exercise of the Placement Agent Warrants in accordance with the terms of such Placement Agent Warrants, will be validly issued, fully paid and non-assessable.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The opinion expressed herein is limited to the
laws of the State of Delaware and the State of New York. This opinion letter is limited to the laws in effect as of the date the Registration
Statement is declared effective by the Commission and is provided exclusively in connection with the public offering contemplated by the
Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This opinion letter is qualified to the extent
that the enforceability of any applicable agreement, document, or instrument discussed herein may be limited by or subject to bankruptcy,
insolvency, fraudulent transfer or conveyance, reorganization, moratorium or other similar laws relating to or affecting creditors&rsquo;
rights generally, and general equitable or public policy principles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This opinion letter speaks only as of the date
hereof and we assume no obligation to update or supplement this opinion letter if any applicable laws change after the date of this opinion
letter or if we become aware after the date of this opinion letter of any facts, whether existing before or arising after the date hereof,
that might change the opinions expressed above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This opinion letter is furnished in connection
with the filing of the Registration Statement and may not be relied upon for any other purpose without our prior written consent in each
instance. Further, no portion of this letter may be quoted, circulated or referred to in any other document for any other purpose without
our prior written consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We hereby consent to the filing of this opinion
as an exhibit to the Registration Statement and to the reference of this firm under the caption &ldquo;Legal Matters&rdquo; in the prospectus
which is made part of the Registration Statement. In giving this consent, we do not thereby admit that we come within the category of
persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%">Very truly yours,</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><I>/s/ Lucosky Brookman LLP</I></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Lucosky Brookman LLP</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>3
<FILENAME>ea025198001ex10-4_brag.htm
<DESCRIPTION>AMENDMENT TO PLACEMENT AGENT AGREEMENT, DATED JULY 31, 2025, BY AND BETWEEN BRAG HOUSE HOLDINGS, INC. AND REVERE SECURITIES LLC
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.4</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>AMENDMENT TO PLACEMENT AGENT AGREEMENT</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt">This Amendment dated July 31, 2025 (this (&ldquo;Amendment&rdquo;)
is to the Placement Agent Agreement (the &ldquo;Original Placement Agent Agreement&rdquo;) dated as of July 24, 2025, between Revere Securities
LLC (&ldquo;<U>Placement Agent</U>&rdquo;) and Brag House Holdings, Inc. (the &ldquo;<U>Company</U>&rdquo;).</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt">WHEREAS, the Placement Agent and the Company desire to amend section
5 of the Original Placement Agent Agreement in its entirety.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt">NOW, THEREFORE, in consideration of the premises and mutual covenants
herein contained, the parties agree as follows:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.25in"></TD><TD STYLE="text-align: justify; width: 0.25in">1.</TD><TD STYLE="text-align: justify">Amendments.</TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in"></TD><TD STYLE="text-align: justify; width: 0.25in">(a)</TD><TD STYLE="text-align: justify">Section 5 of the Original Placement Agent Agreement is hereby deleted in its entirety and replaced with the following:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify">&ldquo;<B>5. <U>Warrant Coverage</U>.
</B>The Company shall issue to Placement Agent or its designees at the Closing of the Placement, warrants (the &ldquo;Placement Agent
Warrants&rdquo;) to purchase that number of shares of common stock of the Company equal to eight-point-zero percent (8.0%) of the aggregate
number of shares of common stock (or common stock equivalent, if applicable) placed in the Closing of the Placement, wherein such placement
is to investors which have been sourced or introduced by the Placement Agent. Notwithstanding the foregoing, the Company shall issue to
Placement Agent or its designees at the Closing of the Placement, Placement Agent Warrants equal to six-point-zero percent (6.0%) of the
aggregate number of shares of common stock (or common stock equivalent, if applicable) placed in the Closing of the Placement that are
not sourced or introduced by the Placement Agent. If the Securities included in an Offering are convertible, the Placement Agent Warrants
shall be determined by dividing the gross proceeds raised in the Placement by the offering price . The Placement Agent Warrants shall
be in a customary form reasonably acceptable to Placement Agent, have a term of five (5) years and an exercise price equal to 100% of
the offering price per share or per unit.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify">The Original Placement Agent Agreement shall be amended by adding Section 5B as follows:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify">Section 5A. Right of First Refusal.
If, from the date hereof until the 18-month anniversary following consummation of the Placement, the Company or any of its subsidiaries
(a) decides to dispose of or acquire business units or acquire any of its outstanding securities or make any exchange or tender offer
or enter into a merger, consolidation or other business combination or any recapitalization, reorganization, restructuring or other similar
transaction, including, without limitation, an extraordinary dividend or distributions or a spin-off or split-off, Placement Agent (or
any affiliate designated by Placement Agent) shall have the right to act as the Company&rsquo;s exclusive financial advisor for any such
transaction; or (b) decides to finance or refinance any indebtedness, Placement Agent (or any affiliate designated by Placement Agent)
shall have the right to act as sole book-runner, sole manager, sole placement agent or sole agent with respect to such financing or refinancing;
or (c) decides to raise funds by means of a public offering (including at-the-market facility) or a private placement or any other capital-raising
financing of equity, equity-linked or debt securities, Placement Agent (or any affiliate designated by Placement Agent) shall have the
right to act as sole book-running manager, sole underwriter or sole placement agent for such financing. If Placement Agent or one of its
affiliates decides to accept any such engagement, the agreement governing such engagement will contain, among other things, provisions
for customary fees for transactions of similar size and nature and the provisions of this Agreement, including indemnification, which
are appropriate to such a transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(c)</TD><TD STYLE="text-align: justify">he Original Placement Agent Agreement shall be amended by adding Section 5B as follows:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify">&ldquo;Section 5B. Fee Tail. Placement
Agent shall be entitled to compensation under Section 3 and Section 5 hereunder, calculated in the manner set forth therein, with respect
to any public or private offering or other financing or capital-raising transaction of any kind (&ldquo;Tail Financing&rdquo;) to the
extent that such financing or capital is provided to the Company by investors whom Placement Agent had introduced to the Company and/or
invested in the Offering during the Term, if such Tail Financing is consummated at any time within the 24-month period following the Closing
of the Placement.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 22.5pt 0pt 49.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 22.5pt 0pt 49.5pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Revere Securities LLC</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>By: </B></FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>/s/ William Moreno</I></B></FONT></TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name:&nbsp; </B></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William Moreno</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title: </B></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Chairman</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Brag House Holdings, Inc.</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>By<I>: </I></B></FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>/s/ Lavell Juan Malloy, II</I></B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name:&nbsp; </B></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lavell Juan Malloy, II</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title: </B></FONT></TD>
    <TD STYLE="font-size: 10pt; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Chief Executive Officer</B></FONT></TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>ea025198001ex23-1_brag.htm
<DESCRIPTION>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM (MARCUM LLP)
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0pt; text-align: right"><B>Exhibit 23.1</B></P>

<P STYLE="margin: 0pt; text-align: center"><B>&nbsp;<FONT STYLE="text-transform: uppercase">&nbsp;</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B><U>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">We consent to the incorporation by reference in this
Registration Statement on Form S-1 of our report dated May 7, 2025 with respect to the financial statements of Brag House Holdings, Inc.
for the year ended December 31, 2024 included in the Annual Report on Form 10-K. We also consent to the reference to us under the heading
&ldquo;Experts&rdquo; in such Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">/s/ <FONT STYLE="font-variant: small-caps">Marcum LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Boston, MA</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">August 11, 2025</P>
<P STYLE="margin: 0pt; text-align: center"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>5
<FILENAME>ea025198001ex-fee_brag.htm
<DESCRIPTION>FILING FEE TABLE
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Template (c) 2024-2025 Novaworks, LLC -->
<!-- Field: Set; Name: AliasFileType; Value: Forms View; Template: Fee Exhibit\Fee Exhibit FE.xds -->
<!-- Field: Set; Name: Platform; Value: Novaworks Fee Exhibit Editor; Version: 1.2b -->
<!-- Field: Set; Name: Control; Value: VGVtcGxhdGU6IChkZWZhdWx0KQ0KQmFzZSBGb250OiBUaW1lcyBOZXcgUm9tYW4sIFRpbWVzLCBTZXJpZg0KQ2FwdGlvbiBTaXplOiAxMnB0DQpUYWJsZSBUaXRsZSBTaXplOiAxMXB0DQpUYWJsZSBIZWFkIFNpemU6IDhwdA0KVGFibGUgQm9keSBTaXplOiAxMHB0 -->
<!-- Field: Set; Name: MD5; Value: 20270723e5f1f986979dd4bd80551bd8 -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025">
<head>
  <title>Filing Fee Exhibit</title>
  <meta http-equiv="Content-Type" content="text/html"/>
  </head>
<body style="font: 10pt Times New Roman, Times, Serif">

<div style="display: none">
  <ix:header>
    <ix:hidden>
      <ix:nonNumeric name="ffd:SubmissnTp" contextRef="c_report" id="fee_001">S-1</ix:nonNumeric>
      <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="c_report" id="fee_002">EX-FILING FEES</ix:nonNumeric>
      <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="c_report" id="fee_003">0001903595</ix:nonNumeric>
      </ix:hidden>
    <ix:references>
      <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd" xlink:type="simple"/>
      </ix:references>
    <ix:resources>
      <xbrli:context id="c_offering_1">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903595</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>1</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-08-06</xbrli:startDate>
          <xbrli:endDate>2025-08-06</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_offering_2">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903595</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>2</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-08-06</xbrli:startDate>
          <xbrli:endDate>2025-08-06</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_report">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001903595</xbrli:identifier>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-08-06</xbrli:startDate>
          <xbrli:endDate>2025-08-06</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:unit id="USD">
        <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="pure">
        <xbrli:measure>xbrli:pure</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="shares">
        <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unit>
      </ix:resources>
    </ix:header>
  </div>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt; text-align: right">Ex-Filing Fees</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; text-align: center">CALCULATION OF FILING FEE TABLES</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; text-align: center"><ix:nonNumeric name="ffd:FormTp" contextRef="c_report" id="fee_004">S-1</ix:nonNumeric></p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt; text-align: center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="c_report" id="fee_005">Brag House Holdings, Inc.</ix:nonNumeric></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; border-top: Gray 3pt double; padding-top: 6pt; text-align: center; margin-top: 0pt; margin-bottom: 4pt">Table 1: Newly Registered and Carry Forward Securities</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="font-size: 2pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="width: 12%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 6.5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td></tr>
<tr style="font-size: 8pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="border-bottom: Black 1pt solid">Line Item Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Class Title</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Notes</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Calculation<br/> Rule</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Amount Registered</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Proposed Maximum Offering<br/> Price Per Unit</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Maximum Aggregate Offering Price</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Rate</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Amount of Registration Fee</td></tr>
<tr style="font-size: 2pt; vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="22" style="padding-top: 2pt; font-style: italic; text-align: center; padding-bottom: 2pt">Newly Registered Securities</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_1" format="ixt:booleanfalse" id="fee_006">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_1" id="fee_007">Equity</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_1" id="fee_008">Common Stock, par value $0.0001 per share</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(1)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:FeesOthrRuleFlg" contextRef="c_offering_1" format="ixt:booleantrue" id="fee_009">Other</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="shares" decimals="0" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_010">15,923,567</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_011">1.15</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_012">18,312,102.05</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_013">0.0001531</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_014">2,803.58</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_2" format="ixt:booleanfalse" id="fee_015">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_2" id="fee_016">Equity</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_2" id="fee_017">Common Stock, par value $0.0001 per share issuable upon exercise of the Warrants</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(2)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:FeesOthrRuleFlg" contextRef="c_offering_2" format="ixt:booleantrue" id="fee_018">Other</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="shares" decimals="0" format="ixt:numdotdecimal" contextRef="c_offering_2" id="fee_019">16,981,110</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="fee_020">1.15</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="fee_021">19,528,276.50</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="fee_022">0.0001531</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="fee_023">2,989.78</ix:nonFraction></td></tr>
<tr style="font-size: 4pt; vertical-align: top; text-align: left">
  <td style="width: 11%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Offering Amounts:</td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="fee_024">37,840,378.55</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="fee_025">5,793.36</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fees Previously Paid:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlPrevslyPdAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="fee_026">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fee Offsets:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 1pt solid">&#160;</td>
  <td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="fee_027">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Net Fee Due:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 3pt double">$</td>
  <td style="border-bottom: Black 3pt double; text-align: right"><ix:nonFraction name="ffd:NetFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="fee_028">5,793.36</ix:nonFraction></td></tr>
</table>

<p style="font: bold 8pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 6pt">__________________________________________<br/>
Offering Note(s)</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(1)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_1" id="fee_029">The shares of common stock of Brag House Holdings, Inc. (the &#8220;Registrant&#8221;) will be offered for resale by the selling stockholders pursuant to the prospectus contained herein. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), this registration statement also covers any additional number of shares of common stock issuable upon stock splits, stock dividends, or other distribution, recapitalization or similar events with respect to the shares of common stock being registered pursuant to this registration statement.<br/><br/>This registration statement registers the resale by the selling stockholders of up to an aggregate of 32,904,677 shares of common stock, par value $0.0001 per share, issued by the Registrant pursuant to (a) a Securities Purchase Agreement, dated July 24, 2025, consisting of (i) 15,923,567 shares of common stock issuable upon conversion of 15,000 shares of Series B Preferred Stock, par value $0.0001 per share and (ii) warrants to purchase up to an aggregate of 15,923,567 shares of common stock; and (b) a Placement Agency Agreement, dated July 24, 2025, subsequently amended and restated on July 31, 2025, consisting of 1,057,543 placement agent warrants exercisable for 1,057,543 shares of common stock.<br/><br/>Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(c) of the Securities Act, based upon the average of the high and low prices for a share of common stock as reported on the Nasdaq Capital Market on August 7, 2025, which date is a date within five business days of the filing of the registration statement for the registration of the securities listed in the table above.</ix:nonNumeric></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(2)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_2" id="fee_030">The shares of common stock of Brag House Holdings, Inc. (the &#8220;Registrant&#8221;) will be offered for resale by the selling stockholders pursuant to the prospectus contained herein. Pursuant to Rule 416under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), this registration statement also covers any additional number of shares of common stock issuable upon stock splits, stockdividends, or other distribution, recapitalization or similar events with respect to the shares of common stock being registered pursuant to this registration statement.<br/><br/>This registration statement registers the resale by the selling stockholders of up to an aggregate of 32,904,677 shares of common stock, par value $0.0001 per share, issued by the Registrantpursuant to (a) a Securities Purchase Agreement, dated July 24, 2025, consisting of (i) 15,923,567 shares of common stock issuable upon conversion of 15,000 shares of Series B Preferred Stock,par value $0.0001 per share and (ii) warrants to purchase up to an aggregate of 15,923,567 shares of common stock; and (b) a Placement Agency Agreement, dated July 24, 2025, subsequentlyamended and restated on July 31, 2025, consisting of 1,057,543 placement agent warrants exercisable for 1,057,543 shares of common stock.<br/><br/>Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(c) of the Securities Act, based upon the average of the high and low prices for a share ofcommon stock as reported on the Nasdaq Capital Market on August 7, 2025, which date is a date within five business days of the filing of the registration statement for the registration of the securitieslisted in the table above.</ix:nonNumeric></td></tr>
  </table>


</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !, )4# 2(  A$! Q$!_\0
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MV@-2OM3M-%_9O\$ZS_9MS-%.-*U3QMJ4D$*3RPQ2W"66GS>2LOE-M:3:A8,
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MZ>B_L?$:O96]79+R/RF^&'_)2? /_8X^'/\ TZVM?M3XA_Y%[Q#_ -@?5O\
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M#6DZG;QW=BGBOQ!=3^7K%S;2J\-Q)I>GVLIL$=2L5U,;C&^.-E_JOPMP&$X
M\.\S\3\RQ&88B>,I5_J^387%3I9?7HT,9#+\)#$TDI4ZV+Q&,]I.->K%?5:%
M.2BG*5I?R1XJX[&^(7B)E?AAEN'RZ@L%5HK$9OB<-&ICJ56KA)8_&RHU;QJT
M\)A\+[*FZ%.7^T8B:D[):?!_A;P!XPE2VFB\ ^+Y8W1)(YH_!OB!XI8R RR1
M2KIA21'P"&1F5\Y&017O_@VVGLKM[2ZMKBQN;9_)FM+NVEM+FVD4D&&>VG2*
M:"0!AN22-'&>@S@_V31VT$$2QQPQ1HH 1(HD1(XQ@!(T1555 Z  8 ..Q/\
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M/^)I;=/\]*_<!HXY4EBE19(I?,CDC<!D>-Q(KHRG@JRDA@<@@D'BOP_^&/\
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MEM;:=HK2:?;P:+),;.**QE_>VJ+%MAD 9-I KY"TMG=\JO9]%W[?:_$_>?\
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M ,E)^'__ &.7AW_TZ6]?M3XBS_PCOB#M_P 2C5>/K9W((_SZ5^*WPQ_Y*3X
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4OEDQVS-$I) )-%>W8 Z "BH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>ex5-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  O ,@# 2(  A$! Q$!_\0
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MX5\47NIW5S9[+^&S\ ^//[ OM U%6\[3=3\1ZK;V,<S:E>QKL_MS_P#!)/\
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MX+URZ2YC@UG4KG4].LM7^P:A>@6=NMM]I?L;?\&]?C?]K/\ 8"^$G[<'A_\
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M;G\;_MP?\$U?VLK#QMHGQ)L?#>@77[.7BS7M'\">'_A[X3\):%#IOAOPE-X
M\=W&K_!OXE>&K2].NZK9^*;(^"/&T6J:]JR+<7$TNH:G=_"_Q[_X-D?C]^QW
M\)?$?[3/[!'_  4!_:'U_P#:+^$WA'7/'>L>&GBD^'&N_$J7PWI]QXCU.Q^'
M?BCP)XFCO]$\0:D-/N(M \._$"'QYH^NW0MM'U'5;1YHKV7XL_;&_P""H_Q3
M_P""AG_! ?P5XK^)GB6[TO\ :+^ '[=OPP^$/Q.\8>#-1U;P/+\1=,U?X/\
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MWQYXS\#+>6[BYB&K>$)M1LM*\4V*WN;U])\5C6M+N;M5FN;.128A^DG[7?\
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1))+RT-(1Y(J-V[=7OO<__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Aug. 06, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0001903595<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">Brag House Holdings, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">S-1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings<br></strong></div></th>
<th class="th">
<div>Aug. 06, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=1', window );">Offering: 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">15,923,567<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">1.15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 18,312,102.05<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 2,803.58<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">The shares of common stock of Brag House Holdings, Inc. (the &#8220;Registrant&#8221;) will be offered for resale by the selling stockholders pursuant to the prospectus contained herein. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), this registration statement also covers any additional number of shares of common stock issuable upon stock splits, stock dividends, or other distribution, recapitalization or similar events with respect to the shares of common stock being registered pursuant to this registration statement.<br/><br/>This registration statement registers the resale by the selling stockholders of up to an aggregate of 32,904,677 shares of common stock, par value $0.0001 per share, issued by the Registrant pursuant to (a) a Securities Purchase Agreement, dated July 24, 2025, consisting of (i) 15,923,567 shares of common stock issuable upon conversion of 15,000 shares of Series B Preferred Stock, par value $0.0001 per share and (ii) warrants to purchase up to an aggregate of 15,923,567 shares of common stock; and (b) a Placement Agency Agreement, dated July 24, 2025, subsequently amended and restated on July 31, 2025, consisting of 1,057,543 placement agent warrants exercisable for 1,057,543 shares of common stock.<br/><br/>Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(c) of the Securities Act, based upon the average of the high and low prices for a share of common stock as reported on the Nasdaq Capital Market on August 7, 2025, which date is a date within five business days of the filing of the registration statement for the registration of the securities listed in the table above.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=2', window );">Offering: 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Common Stock, par value $0.0001 per share issuable upon exercise of the Warrants<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">16,981,110<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">1.15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 19,528,276.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 2,989.78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">The shares of common stock of Brag House Holdings, Inc. (the &#8220;Registrant&#8221;) will be offered for resale by the selling stockholders pursuant to the prospectus contained herein. Pursuant to Rule 416under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), this registration statement also covers any additional number of shares of common stock issuable upon stock splits, stockdividends, or other distribution, recapitalization or similar events with respect to the shares of common stock being registered pursuant to this registration statement.<br/><br/>This registration statement registers the resale by the selling stockholders of up to an aggregate of 32,904,677 shares of common stock, par value $0.0001 per share, issued by the Registrantpursuant to (a) a Securities Purchase Agreement, dated July 24, 2025, consisting of (i) 15,923,567 shares of common stock issuable upon conversion of 15,000 shares of Series B Preferred Stock,par value $0.0001 per share and (ii) warrants to purchase up to an aggregate of 15,923,567 shares of common stock; and (b) a Placement Agency Agreement, dated July 24, 2025, subsequentlyamended and restated on July 31, 2025, consisting of 1,057,543 placement agent warrants exercisable for 1,057,543 shares of common stock.<br/><br/>Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(c) of the Securities Act, based upon the average of the high and low prices for a share ofcommon stock as reported on the Nasdaq Capital Market on August 7, 2025, which date is a date within five business days of the filing of the registration statement for the registration of the securitieslisted in the table above.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRegd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of securities being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRegd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesOthrRuleFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesOthrRuleFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxOfferingPricPerScty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum offering price per share/unit being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxOfferingPricPerScty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal4lItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Aug. 06, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 37,840,378.55<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">5,793.36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">$ 5,793.36<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>20</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea025198001ex-fee_brag.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ea025198001ex-fee_brag.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ea025198001ex-fee_brag.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="ea025198001ex-fee_brag.htm">ea025198001ex-fee_brag.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="28">http://xbrl.sec.gov/ffd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea025198001ex-fee_brag.htm": {
   "dts": {
    "inline": {
     "local": [
      "ea025198001ex-fee_brag.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
     ]
    }
   },
   "keyStandard": 20,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/ffd/2025": 2,
    "http://xbrl.sec.gov/dei/2025": 1
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025": 28,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea025198001ex-fee_brag.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea025198001ex-fee_brag.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea025198001ex-fee_brag.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea025198001ex-fee_brag.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea025198001ex-fee_brag.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea025198001ex-fee_brag.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001213900-25-074419-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-25-074419-xbrl.zip
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MPWM.<*<1NQ'N^-3IN/W;)YU<.YDDSWEV-3Z2S6X0N(SZ/>KBPYOI.:BJ-K0
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M KM[=M(A%-@AQ-\+;WZ25]@(_.V7NF49V],KI6K W'X-.G9=;,LJNLQ!OR=
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K,3DX,# Q97@M9F5E7V)R86<N:'1M4$L%!@     !  $ 2    ,\,      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>ea025198001ex-fee_brag_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="c_offering_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903595</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-06</startDate>
            <endDate>2025-08-06</endDate>
        </period>
    </context>
    <context id="c_offering_2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903595</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>2</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-06</startDate>
            <endDate>2025-08-06</endDate>
        </period>
    </context>
    <context id="c_report">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001903595</identifier>
        </entity>
        <period>
            <startDate>2025-08-06</startDate>
            <endDate>2025-08-06</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <ffd:SubmissnTp contextRef="c_report" id="fee_001">S-1</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="c_report" id="fee_002">EX-FILING FEES</ffd:FeeExhibitTp>
    <dei:EntityCentralIndexKey contextRef="c_report" id="fee_003">0001903595</dei:EntityCentralIndexKey>
    <ffd:FormTp contextRef="c_report" id="fee_004">S-1</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="c_report" id="fee_005">Brag House Holdings, Inc.</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg contextRef="c_offering_1" id="fee_006">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_1" id="fee_007">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_1" id="fee_008">Common Stock, par value $0.0001 per share</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="c_offering_1" id="fee_009">true</ffd:FeesOthrRuleFlg>
    <ffd:AmtSctiesRegd
      contextRef="c_offering_1"
      decimals="0"
      id="fee_010"
      unitRef="shares">15923567</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_011"
      unitRef="USD">1.15</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_012"
      unitRef="USD">18312102.05</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_013"
      unitRef="pure">0.0001531</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_014"
      unitRef="USD">2803.58</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="c_offering_2" id="fee_015">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_2" id="fee_016">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_2" id="fee_017">Common Stock, par value $0.0001 per share issuable upon exercise of the Warrants</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="c_offering_2" id="fee_018">true</ffd:FeesOthrRuleFlg>
    <ffd:AmtSctiesRegd
      contextRef="c_offering_2"
      decimals="0"
      id="fee_019"
      unitRef="shares">16981110</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="c_offering_2"
      decimals="INF"
      id="fee_020"
      unitRef="USD">1.15</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_2"
      decimals="INF"
      id="fee_021"
      unitRef="USD">19528276.50</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_2"
      decimals="INF"
      id="fee_022"
      unitRef="pure">0.0001531</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_2"
      decimals="INF"
      id="fee_023"
      unitRef="USD">2989.78</ffd:FeeAmt>
    <ffd:TtlOfferingAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_024"
      unitRef="USD">37840378.55</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_025"
      unitRef="USD">5793.36</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_026"
      unitRef="USD">0.00</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_027"
      unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_028"
      unitRef="USD">5793.36</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="c_offering_1" id="fee_029">The shares of common stock of Brag House Holdings, Inc. (the &#x201c;Registrant&#x201d;) will be offered for resale by the selling stockholders pursuant to the prospectus contained herein. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;), this registration statement also covers any additional number of shares of common stock issuable upon stock splits, stock dividends, or other distribution, recapitalization or similar events with respect to the shares of common stock being registered pursuant to this registration statement.&lt;br/&gt;&lt;br/&gt;This registration statement registers the resale by the selling stockholders of up to an aggregate of 32,904,677 shares of common stock, par value $0.0001 per share, issued by the Registrant pursuant to (a) a Securities Purchase Agreement, dated July 24, 2025, consisting of (i) 15,923,567 shares of common stock issuable upon conversion of 15,000 shares of Series B Preferred Stock, par value $0.0001 per share and (ii) warrants to purchase up to an aggregate of 15,923,567 shares of common stock; and (b) a Placement Agency Agreement, dated July 24, 2025, subsequently amended and restated on July 31, 2025, consisting of 1,057,543 placement agent warrants exercisable for 1,057,543 shares of common stock.&lt;br/&gt;&lt;br/&gt;Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(c) of the Securities Act, based upon the average of the high and low prices for a share of common stock as reported on the Nasdaq Capital Market on August 7, 2025, which date is a date within five business days of the filing of the registration statement for the registration of the securities listed in the table above.</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="c_offering_2" id="fee_030">The shares of common stock of Brag House Holdings, Inc. (the &#x201c;Registrant&#x201d;) will be offered for resale by the selling stockholders pursuant to the prospectus contained herein. Pursuant to Rule 416under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;), this registration statement also covers any additional number of shares of common stock issuable upon stock splits, stockdividends, or other distribution, recapitalization or similar events with respect to the shares of common stock being registered pursuant to this registration statement.&lt;br/&gt;&lt;br/&gt;This registration statement registers the resale by the selling stockholders of up to an aggregate of 32,904,677 shares of common stock, par value $0.0001 per share, issued by the Registrantpursuant to (a) a Securities Purchase Agreement, dated July 24, 2025, consisting of (i) 15,923,567 shares of common stock issuable upon conversion of 15,000 shares of Series B Preferred Stock,par value $0.0001 per share and (ii) warrants to purchase up to an aggregate of 15,923,567 shares of common stock; and (b) a Placement Agency Agreement, dated July 24, 2025, subsequentlyamended and restated on July 31, 2025, consisting of 1,057,543 placement agent warrants exercisable for 1,057,543 shares of common stock.&lt;br/&gt;&lt;br/&gt;Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(c) of the Securities Act, based upon the average of the high and low prices for a share ofcommon stock as reported on the Nasdaq Capital Market on August 7, 2025, which date is a date within five business days of the filing of the registration statement for the registration of the securitieslisted in the table above.</ffd:OfferingNote>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
